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Abstract
Skin cancer is the most common form of cancer in North America, and melanoma
is the most dangerous type of skin cancer. Melanoma originates from melanocytes in
the epidermis and has a high tendency to develop away from the skin surface and cause
metastasis through the bloodstream. Early diagnosis is known to help improve survival
rates. Under the current diagnosis, the initial examination of the potential melanoma
patient is done via naked eye screening or standard photographic images of the lesion.
From this, the accuracy of diagnosis varies depending on the expertise of the clinician.
Radiomics is a recent cancer diagnostic tool that centers around the high throughput
extraction of quantitative and mineable imaging features from medical images to identify
tumor phenotypes. Radiomics focuses on optimizing a large number of features through
computational approaches to develop a decision support system for improving individu-
alized treatment selection and monitoring. While radiomics has shown great promise for
screening and analyzing different forms of cancer such as lung cancer and prostate cancer,
to the best of our knowledge, radiomics has not been previously adopted for skin cancer,
especially melanoma.
This work presents a dermal radiomics framework, which is a novel computer-aided
melanoma diagnosis. While most computer-aided melanoma screening systems follow the
conventional diagnostic scheme, the proposed work utilizes the physiological biomarker
information. To extract physiological biomarkers, non-linear random forest inverse light-
skin interaction model is proposed. The construction of dermal radiomics sequence is
followed using the extracted physiological biomarkers, and the dermal radiomics framework
for melanoma is completed by constructing diagnostic decision system based on random
forest classification algorithm.
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Chapter 1
Introduction
This thesis presents dermal radiomics, which is a new approach of screening and diag-
nosing melanoma with the help of computer system. To construct this dermal radiomics
framework, three items are presented: 1) physiological biomarker extraction, 2) dermal
radiomics sequence construction and 3) feature analysis of dermal radiomics sequence. In
this chapter, we briefly explain each component of dermal radiomics, which are malignant
melanoma and radiomics.
1.1 Melanoma
Melanoma is the most lethal form of skin cancer [63]. In Canada alone, an estimated 6,000
new cases are diagnosed as melanoma each year, and 0.2 million cases worldwide [27, 49].
With an early diagnosis, melanoma can be completely cured with a simple extraction of
the cancerous tissue. However, as melanoma advances into later stages, the cancer can
spread and the prognosis becomes dismal. In North America, melanoma cases are initially
diagnosed by a dermatologist or general practitioner, and confirmed by a pathologist (given
a biopsy by the dermatologist). Furthermore, the initial diagnosis is usually performed with
naked-eye examination for determining suspicious malignant lesions, sometimes with the
aid of a dermoscope [47]. A dermoscope is an optical device used by some dermatologists
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to magnify skin lesion and to remove skin surface reflection. Even with the help of a
dermoscope, the visual examination may bring difficulties to correctly identify melanoma.
For example, melanoma at early to mid stages is difficult to be distinguished from benign
dysplastic nevi (i.e., moles) by visual inspection. Moreover, melanoma can be observed
in many different shapes and forms, which makes it even more difficult to identify a new
lesion as a melanoma. While identifying melanoma as early as possible is crucial for the
better patient prognosis, accurate diagnosis is still challenging for any physician.
1.2 Radiomics
Medical imaging is conventionally used for the diagnostic purpose to find a potential tumor
and to monitor its’ changes over time. With the advancement in imaging acquisition tech-
nique, medical imaging extends from its primary role to become a non-invasive prognostic
tool by providing objective and precise quantitative imaging descriptors. Radiomics has
recently emerged, and the principle idea of radiomics is to convert imaging data into a
large number of quantitative and mineable imaging features using data-characterization
algorithms [2]. Although each extracted feature may not have any known clinical signifi-
cance, radiomics focuses on optimizing a large number of features through computational
approaches to develop a decision support system for improving individualized treatment
selection and monitoring [91].
Figure 1.1: The radiomics workflow is presented, which involves image acquisition of tumor,
its segmentation, feature extraction and analysis for prognosis.
The radiomics workflow involves four processes as shown in Fig. 1.1 [75]. The first
step is the imaging acquisition for diagnostic or planning purposes. From the image, the
segmentation of the tumor is performed automatically or by an experienced radiologist.
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Next, quantitative imaging features are extracted based on the tumor segmentation, and
the feature selection procedure is followed to find the most informative features. The
selected features are then analyzed for their relationship with treatment outcomes.
1.3 Radiomics-driven Computer-aided Melanoma Screen-
ing System
While radiomics has shown great promise for screening and analyzing different forms of
cancer such as lung, head and neck, and prostate cancer [91, 2, 65], to the best of our knowl-
edge, radiomics has not been previously adopted for skin cancer, especially melanoma. As
such, radiomics is expected to have benefits for melanoma screening, especially since clinical
screening currently relies solely on visual assessment of skin lesions.
Therefore, we propose a radiomics-driven computer-aided melanoma screening system,
which is now referred to as dermal radiomics throughout the thesis. The dermal radiomics
framework consists of four processes, and its’ workflow is shown in Fig. 1.2. Imaging
modalities used for dermal radiomics are standard camera images or dermascopic images.
Segmentation is conducted manually and is coupled with an extra pre-processing step.
Pre-processing in dermal radiomics is used to ensure that each image acquired is min-
imized from skin surface reflection and is scale- and rotation- invariant. Segmentation
process will be explained in detail in Section 5.5.2. The next step in radiomics is feature
extraction. In the proposed dermal radiomics, this step is further divided into two as
physiological biomarker extraction and dermal radiomics sequence construction. In physi-
ological biomarker extraction, we extract sub-dermal physiological biomarkers from image
data such as melanin and hemoglobin, which are not typically available to dermatologists
but only to pathologists via a pathological report. Based on the extracted physiological
biomarkers, a dermal radiomics sequence is constructed. Lastly, dermal radiomics em-
ploys classification and feature selection algorithm to analyze the sequence and provide an
accurate diagnosis of a skin lesion.
3
Figure 1.2: The proposed radiomics-driven melanoma screening system is presented.
4
1.4 Motivation
The motivation for developing dermal radiomics can be explained in three ways.
First, as aforementioned, early diagnosis is the key for improving prognosis of patients
with melanoma because melanoma likely penetrates deeper and causes metastasis [8]. Cur-
rent clinical examination primarily relies on the subjectivity of clinicians and dermatol-
ogists, and thus, the diagnosis may be different from one clinician to another depending
on their expertise. Although most dermatologists use the standard diagnostic scheme for
clinical examination, the reported accuracy of diagnosing melanoma with the unaided eye
is only about 60% [67]. Therefore, dermal radiomics can help dermatologists and clini-
cians to make more robust decision using quantitative image features, rather than solely
depending on their training.
Second, even though the clinicians and dermatologists conduct the initial diagnosis, the
diagnosis is confirmed by the pathological report through biopsy. Since the process of pro-
ducing the pathological report through biopsy is time-consuming, expensive and painful, it
is especially challenging for those who have many moles that need to be dissected for biopsy.
Therefore, an accurate initial diagnosis to reduce any unnecessary biopsy is crucial. The
fundamental limitation of the initial diagnosis by visual inspection, is that this only exam-
ines the surface of the lesion, while pathological report investigates sub-dermal pathology.
Given that the melanoma originates from melanocytes, and melanocytes are responsible for
producing melanin, investigating the activities of physiological biomarkers such as melanin
on the suspicious lesion should provide additional knowledge for dermatologists to improve
the accuracy on the diagnosis of the melanoma before biopsy.
Last, dermal radiomics can be used as a tele-medicine tool to find potential malignant
lesions. Under current practice, any abnormal lesions should be confirmed by clinicians
or dermatologists, and many abnormal lesions could be ignored because people do not go
to doctors. Moreover, for those who live in remote area or in an underdeveloped country,
the access to clinicians or dermatologists is not easy. This will inevitably delay the initial
diagnosis as well as the proper treatment in a reasonable time frame to prevent spread of
the cancer. With the proposed dermal radiomics, patients can upload or send a image of
suspicious lesion and get pre-diagnosed for the severity of the lesion. If the screening system
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identifies a lesion to require immediate attention by clinicians, then they can proceed with
more confidence and improve the diagnosis accuracy for patients.
1.5 Thesis Contributions
The thesis makes following contributions:
• In Chapter 3 and 4, a novel method to extract the concentration of physiological
biomarkers for dermal radiomics is introduced and validated. Most existing tech-
niques for physiological biomarker extraction are based on a linear light-skin inter-
action model, which describes only single light-skin interaction, namely, absorption.
The proposed model uses a non-linear, forward light-skin interaction model, which ac-
counts for various interactions including surface reflection, subsurface scattering, and
absorption between light and physiological biomarkers. From this forward model, a
non-linear random forest inverse light-skin interaction model is constructed to extract
the concentration of eumelanin, pheomelanin, and hemoglobin.
• In Chapter 5, the construction of a dermal radiomics sequence is proposed. While
most computer-aided melanoma screening system use the feature model that simply
quantifies the existing diagnostic scheme (i.e., ABCD-rule), the proposed feature
model generates a large number of features that characterize a skin lesion based
not only on the appearance of the skin lesion but also the activities of physiological
biomarkers.
• In Chapter 6, feature analysis of the dermal radiomics sequence is designed to com-
plete the dermal radiomics framework. The feature analysis process is divided into
classification analysis and feature selection analysis. Through several validation stud-
ies, a feature selection and classification algorithm, that works effectively with the
dermal radiomics sequence, are provided.
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Chapter 2
Overview of Malignant Melanoma
Skin cancer is the most common form of cancer in North America [104, 27]. This disease
can be categorized into two types depending on its causes: melanoma and non-melanoma.
Melanoma is the most lethal form of skin cancer, and originates from uncontrollable re-
production of melanocytes, which is responsible for producing pigments of skin. Although
non-melanoma skin cancer accounts for the majority of skin cancer cases, more research
focus is aimed at melanoma because non-melanoma skin cancer can be cured with the
proper treatment, while melanoma is more aggressive and becomes incurable as the cancer
progresses[8]. In this chapter, a brief overview of melanoma including risk factors, staging,
and diagnosis is given. Moreover, a overview of skin anatomy relevant to understanding
melanoma and current clinical methods for detecting melanoma is discussed.
2.1 Types of Lesion
2.1.1 Benign Lesions
Benign lesions typically represent any ordinary moles, which rarely cause any harm to hu-
mans, and are subcategorized into two types: melanocytic and non-melanocytic. Melanocytic
lesions develops from melanocytes as the result of excessive production of melanin. Exam-
ples of melanocytic lesions are junctional nevi, compound nevi, intradermal nevi, halo nevi,
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congenital nevi, acquired nevi, dysplastic nevi, spitz nevi, and blue nevi. Non-melanocytic
lesions are moles that do not arise from melanocytes, and dermatofibromas, haemangiomas,
and seborrheic keratosis are the examples of non-melanocytic lesions. These benign lesions
vary in size, shape and colour, and some of them such as dysplatic nevi and seborrheic
keratosis are often misdiagnosed asmelanoma because of their visual resemblance with
melanoma.
2.1.2 Non-melanoma Skin Cancer
Non-melanoma skin cancer (NMSC) is the most common type of cancer in the Caucasian
population. As the name suggests, NMSC refers all types of skin cancers that are not
malignant melanoma. The major difference between NMSC and melanoma is the origin
of the cancer. While melanoma begins from melanocytes, NMSC originates from other
cells in skin. For example, two main types of NMSC are basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC). BCC begins from basal cells of the epidermis, and SCC
is from epidermal keratinocytes. As aforementioned, the incident rate of NMSC is much
greater than that of melanoma. Statistically, more than 2 million new cases of NMSC are
annually reported in North America and Europe. Among NMSC, the BCC’s incident rate
is higher than SCC at 10:1. Even with this high incident rate, NMSC is not registered in
most cancer surveillance systems because it has relatively low mortality rates. However,
one notable NMSC is Merkel cell carcinoma. This one is an aggressive non-melanoma
tumor. It usually occurs for the elderly, who are older than 60 years of age. Mortality rate
for Merkel cell carcinoma is at around 30% at 2 years and average survival at diagnosis is
around 6 to 8 months. This is because it is extremely difficult for Merkel cell carcinoma
to be diagnosed early stage, but it is frequently diagnosed at metastatic stage.
Many potential risk factors contribute to NMSC. One of the most important and signif-
icant risk factors is exposure to UV radiation. The incident rate of NMSC is significantly
low for those who permanently live in high latitude regions where exposure to sun is low.
Moreover, the response of the skin to UV radiation is also an important factor. Typi-
cally, those who have light skin, blond hair and blue eyes have a higher risk of developing
NMSC [62] while it is rather uncommon in black, Asian and Hispanic populations [68, 95].
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Figure 2.1: Estimated age-standardized incidence and mortality rates in Canada(2015).
Other risk factors are aging [118], smoking [39, 21], artificial UV radiation [21, 64] and
chemical carcinogens [138, 107]. Typical treatment options for NMSC are surgery or radi-
ation therapy, depending on the severity of the disease.
2.1.3 Melanoma
Malignant melanoma, commonly referred to simply as melanoma, is the eighth most fre-
quent cancer in both men and women in Canada as shown in Fig. 2.1. By the location
of the lesion, melanoma is defined cutaneous, acral or mucosal. The cutaneous melanoma,
which is the most common melanoma, is common in Caucasian population with fair skin,
while the pigmented population is vulnerable to acral and mucosal melanoma at low inci-
dent rates. Globally, Australia and New Zealand have the highest incident rate and North
America and Europe follow after. Unlike NMSC, melanoma exhibits a high mortality rate.
Melanoma represents only 3% of all skin cancer cases, but it is responsible for 70% of total
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deaths from skin cancer [86]. The unique characteristic of melanoma, which contributes to
the high mortality rate is the strong tendency to penetrate into sub-dermal layer or even
further. The vertical penetration of melanoma is defined as Breslow’s depth [25] and is the
most important prognostic factor for staging.
The origin of melanoma is melanocytes. These cells are responsible for producing
melanin, which is the pigments for skin and hair. Due to its’ nature, the majority of
melanin is present in skin layer, but they could be located anywhere in the body such as
eye, inner ear, or even brain. Clinically, melanoma is categorized into four subtypes: 1)
superficial spreading melanoma, 2) nodular melanoma, 3) acral lentiginous melanoma and
4) lentigo maligna melanoma. The details of each subtype is explained in Fig. 2.2.
2.2 Risk Factors, Staging, and Treatment of Melanoma
2.2.1 Risk Factors
While risk factors are interconnected to each other, four major risk factors are discussed
in this section.
Ultraviolet (UV) Radiation
The most important risk factor of melanoma is UV radiation. At cutaneous level, UV ra-
diation transfers a large amount of energy to sub-dermal tissues and consequently damages
them. The direct damages to DNA may cause various mutations on melanocytes, and the
accumulation of DNA damages may develop melanoma [60, 115].
Two different mechanisms of UV radiation-induced melanoma have been suggested.
First, intense and intermittent UV radiation promotes melanomas on the trunk. This is
more common to young population. Next mechanism involves with chronic exposure to
UV radiation, and in this case, melanomas develop in sun-exposed areas. Older population
is more vulnerable to this mechanism [126].
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Figure 2.2: Visualization of four subtypes of melanoma and their descriptions.
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Atypical Moles
An atypical mole is considered as a benign skin lesion, but is an unusual mole that may
resemble melanoma. A border of atypical mole is usually irregular or poorly defined. The
shape and the colour of this type of mole varies from one to another. A person with more
than five atypical moles has six times higher risk of developing melanoma compared to a
person without any atypical moles [52].
Age
Age is an important risk factor for melanoma. Melanoma occurs most commonly for those
who are aged between 40 and 60 years. The median age at diagnosis of melanoma is 57
years [110], and this is almost one decade earlier than other common cancers such as breast,
lung and colon cancers. Moreover, melanoma is one of the most common cancers in young
adults who are aged between 20 and 29 in Canada [86].
Family History
Family history of melanoma is also a risk factor. First-degree relatives of melanoma patients
have a higher risk of melanoma than those who do not have any positive family history
[56]. Familial melanoma accounts for an estimated 5− 10% of all cases of melanoma [71].
2.2.2 Staging
When the abnormal skin lesion is confirmed as malignant melanoma, the clinicians or
dermatologists determine the stage of the cancer. For melanoma, there are five stages from
stage 0 to stage IV. It is important to determine the accurate stage of melanoma because
the treatment options and prognosis is determined based on the stage of the cancer.
Stage 0 is also called melanoma in situ. At this stage, the suspected lesion is confirmed
malignant, but it is still confined to the upper layer of the skin (epidermis), and there is
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no sign of invasion to dermal layer. The 5-year survival rate for stage 0 is greater than
99% [11].
Stage I is defined as a melanoma that grows as thick as 2mm. While the tumor pene-
trated into dermal layer, there is very low risk for the cancer to spread to lymph nodes or
distant ares. The 5-year survival rate is as high as 95% [13].
At Stage II, the thickness of melanoma is from 2mm to more than 4mm. In most cases,
the tumor is still located in dermal layer, but as it develops, it may penetrate deeper into
subcutaneous fat layer. Ulceration, which is the breakage of epidermis on the top of the
melanoma, may be observed. Stage II is considered intermediate to high risk for distant
metastasis, and the 5-year survival rate is between 45% and 79% [13].
Stage III is defined when tumor spreads into nearby lymph nodes, yet not to distant
areas. At this stage, the depth of tumor no longer matters, and the number of lymph
nodes to which the tumor has spread determines the severity of the condition. The 5-year
survival rate ranges from 24% to 67% [13].
In Stage IV, the melanoma spreads beyond the primary location to more distant areas.
The common locations of metastasis are lung, abdominal organs, or soft tissues. The
prognosis at this stage is extremely poor as the 5-year survival rate is between 9% and
28%, depending on the metastasis location [12].
2.2.3 Treatment
While treatment options highly depend on the stage of melanoma, surgery is the gold
standard of treatment [116]. Surgery could be employed for almost all stages of melanoma.
Depending on the progress of a tumor, different surgical approaches are considered. For
example, if the melanoma is still in its early stages such as Stage 0 or Stage I, simple local
excision or wide local excision may be sufficient to remove the melanoma cells. However, if
the invasion is severe and the tumor is suspected or confirmed for lymph node metastasis,
complete lymph node dissection, which removes not only skin tissue but also lymph nodes,
may be required [83]. Different treatment options other than surgery can be considered
for those who are in the late stage of melanoma, or those who cannot undergo the surgical
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option due to size and/or location of tumor, age of patients, or comorbidity. Other options
can be 1) chemotherapy, which uses drugs to stop spreading of cancerous cells [46]; 2)
radiation therapy, which uses high energy radiation such as x-rays to kill cancerous cells or
keep them from growing [114]; and 3) immunotherapy, which boosts patients’ own immune
systems to fight against cancer [58].
2.3 Diagnosis of Melanoma
Diagnosis of melanoma typically consists of two parts: clinical examination and patho-
logical examination. Clinical examination is conducted by clinicians or dermatologists to
find any suspicious lesions by examining their appearance, while pathological examination
provides more accurate diagnosis by looking into pathology of the lesion, which is acquired
through biopsy.
2.3.1 Clinical Examination
As aforementioned, early detection of melanomic lesion is extremely important for bet-
ter outcome because the survival rate at the late stage of melanoma is dismal. In fact,
melanoma has a relatively low mortality rate compared to other major cancers. This is
because melanomic lesion can be more easily identified by clinicians or even by patient
him/herself. Initial diagnosis is usually conducted with naked eye by clinicians or derma-
tologists, and one of the most commonly used tools is the ABCDE-rule [50, 1].
ABCDE-rule serves as a guideline to distinguish malignant and benign lesion. There
are five components in ABCDE-rule, and each component is explained in Fig. 2.3
2.3.2 Imaging Techniques for Clinical Examination
For the imaging techniques during the clinical examination, the most thorough screening
at the early stage of melanoma is a total body skin examination (TBSE) [57]. The doctor
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Figure 2.3: Clinical Examination: Explanation of ABCDE rule. Adapted from Dirk
Schadendorf et. al. [111]
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scans the entire skin surface of the patient by visual inspection, and examines any sus-
picious moles that could be melanoma. Other than TBSE, many imaging modalities are
employed during the clinical examination for lesion-specific screening, including traditional
photography, dermoscopy, or confocal laser scanning microscopy. In this section, two of
the most common imaging modalities are discussed.
Traditional Photography
Although different imaging modalities have emerged, the traditional or dermatological
photographs still are the primary modality for melanoma. More than half of dermatol-
ogist currently employ dermatological photographs for initial examination[47, 100]. The
photographs typically show single or multiple superficial skin lesions, and these images
reproduce what a dermatologist sees with the naked eye [38]. The images are taken peri-
odically to track any changes in the lesions [14]. Typically, if no changes in colour, size or
shape have been observed, the lesion is treated as benign case. However, if changes occur
in the lesions, a biopsy of the lesion is followed for a more accurate examination.
Dermoscopy
Dermoscopy, which is also known as dermascopy, in vivo cutaneous surface microscopy or
epiluminescence microscopy, is a non-invasive imaging technique. Like traditional photog-
raphy, dermoscopy is imaging only the surface of skin. This imaging modality is equipped
with a magnifying glass that uses the cross-polarized light. Some dermoscopy has im-
mersion fluid to make the layer of skin more transparent to light and eliminate reflection
[70, 82]. The major difference between dermoscopy and traditional photography is that
dermatologists can observe lesions in detail with the magnifying glass and free from light
reflection.
At the late stage of melanoma, because metastasis likely occurs, invasive imaging tech-
niques are required. If the metastasis is thought to be local, and only around lymph nodes,
mid-frequency ultrasound is the ideal imaging method of choice because of high accuracy
[133, 10]. For distant metastasis, cross-sectional diagnostic imaging such as PET/CT, MRI
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or CT are the standard of care [111]. While PET/CT yielded high diagnostic accuracy for
tumor localization compared to whole-body MRI or CT [133], MRI or CT are commonly
used instead, because of the high costs of PET/CT [111]. For cerebral metastases, MRI is
known to be the most precise imaging technique over PET/CT or CT [9].
2.3.3 Pathological Examination
When clinicians determines that the suspicious lesion is malignant based on the clinical
examination, the lesion is further examined in pathological examination. The first step
in pathological examination is biopsy. Biopsy is the process to take a small sample of
the lesion by excising the lesion with a lateral margin of 2-3mm, and vertically reaching
into subcutaneous fat tissue [96]. From the biopsy, pathologists produce histopathological
report on the suspicious lesion, which contains histological features for a correct diagno-
sis, staging, and the subtype of melanoma, and the final diagnosis is made based on the
report [12].
2.3.4 The Computer-aided Melanoma Diagnosis
While conventional approach of melanoma diagnosis was discussed in the previous sections,
the computer-aided melanoma diagnosis was emerged. The purpose of computer-aided
melanoma diagnosis is to aid dermatologists to have the improved accuracy on their di-
agnostic decision by providing quantitative measures on a skin lesion. The quantitative
measures can be constructed from the traditional examination scheme such as ABCD-rule,
or the skin lesion image can be analyzed using texture or shape of the lesion.
Celebi et al. designed the melanoma classification algorithm on dermoscopy images.
They generated a total of 437 features from each image based on the shape (Asymmetry,
aspect ratio, area, and compactness), colour and texture. For the classification, SVM with
radial basis function kernel was used with the feature selection. They obtained a sensitivity
of 93.3% and a specificity of 92.3% on a set of 564 images.
Dreiseitl ran a multi-class classification from pigmented skin lesion. Several classifica-
tion algorithms, including k-nearest neighbors, logistic regression, artificial neural network,
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decision trees, and SVM are tested to classify common nevi, dysplastic nevi, or melanoma
(3 classes). The images were acquired in the form of a dermoscopy image, and 107 morpho-
metric features were extracted for each image. Among tested algorithms, logistic regression,
artificial neural network, and SVM yielded the best results.
Ruiz et al. took a slightly different approach on classification as they combined three
different classification methods (k-nearest neighbors, Bayes classification, and artificial
neural network) as a whole for making decision. A number of feature extracted was 24,
but only six features were employed for classification after the feature selection process.
This technique yielded 78.4% sensitivity and 97.8% specificity.
Cavalcanti et al. used melanin concentrations as features in their melanoma classi-
fication algorithm. To the best of our knowledge, this is the only group to implement
physiological biomarker information into the melanoma screening system. The classifica-
tion is based on two different sets of features: ABCD-rule based features, and features from
concentrations of eumelanin and pheomelanin. Then, they ran two stages of classification
in which the first stage employed k-nearest neighbor model with the ABCD-rule based fea-
tures. The second stage classification used features from melanin concentrations on Bayes
classification. To improve their results, they empirically tested a different combination of
features to find the best set of features, and ultimately obtained 99.7% of sensitivity and
96.2% of specificity.
2.4 Understanding Skin and Physiological Biomark-
ers
Although melanoma can arise in different parts of the body, it primarily originates from
skin. Therefore, to understand the structure of skin and its physiological biomarkers is a
necessary step prior to discussing physiological biomarker extraction model.
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Figure 2.4: Illustration of the skin structure including the epidermis, the papillary dermis,
and the reticular dermis. Image adapted from J. Schofield and W. Robinson [113]
2.4.1 Structure of Skin
The structure of skin can be generally divided into four different layers: the epidermis,
papillary dermis, reticular dermis and subcutaneous fat, as shown in Fig. 2.4. The epider-
mis is the outermost layer of the skin, and is mainly composed of cells called keratinocytes,
which are very strong. Although the epidermis is thin, with a thickness of 0.027-0.15 mm
[43, 73], it acts as an effective barrier to protect the body from bacteria and other mi-
croorganisms. The next layer under the epidermis is the dermis, which is much thicker,
and is responsible for providing strength and structural support to the skin. The dermis
is composed primarily of collagen, and contains blood vessels and lymphatic channels.
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The thickness of dermal layer varies depending on the location, from 0.6-3 mm [43, 73].
For example, the dermis is very thick on the back but thin on the top of the foot. The
papillary dermis is the upper part of the dermis, and the reticular dermis is at the bottom.
The innermost skin layer is the subcutaneous fat, which maintains body heat from loss.
2.4.2 Important Physiological Biomarkers Related to Melanoma
The visible evidence of melanoma is an atypical mole, which results from the uncontrol-
lable production of melanin from melanocytes. Not only is the concentration of melanin
escalated, more blood is also required to supply oxygen and other nutrition at the lesion.
This leads to angiogenesis, which forms new blood vessels from existing ones. Angiogenesis
promotes the circulation of blood and eventually increases the concentration of hemoglobin
at the lesion. Therefore, the concentrations of melanin and hemoglobin can serve as ex-
cellent physiological biomarkers to determine whether a given lesion has the potential to
become cancerous.
Melanin
As mentioned, melanin is produced from melanocytes, which are primarily distributed
in the epidermal layer of skin. There are two main types of melanin: pheomelanin and
eumelanin. The major difference between the two melanins is the colour of pigment they
produce. While pheomelanin gives a red-yellowish colour, eumelanin colours brown-black.
Skin colour is dominated by eumelanin [125], and the ratio between the concentration
of pheomelanin and eumelanin present in human skin varies greatly from individual to
individual. The number could be as low as 0.049 for darker coloured skin and as high
as 0.36 for lighter coloured skin [92]. While a major function of melanin is providing a
protection from ultraviolet (UV) radiation, pheomelanin is known to be more vulnerable
than eumelanin to DNA damages or mutations, caused by UV radiation [31, 136]. This
vulnerability of pheomelanin suggest that pheomelanin plays an important role to develop
a cancer [32, 123].
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There has been several studies to investigate the activities of eumelanin and pheome-
lanin in malignant melanomic lesions for the purpose of the non-invasive diagnosis. For
example, Marcheni et al. [79] conducted a retrospective analysis using diffuse reflectance
spectroscopy, and found that the level of eumelanin increases in the malignant lesions,
when compared to the benign ones. Moreover, they observed the decrease of the level of
pheomelanin in the malignant cases. This finding agrees with the study that was conducted
by Zonio et al. [141]. While the increase of the level of eumelanin is generally agreed, the
activity of pheomelanin in malignant lesion is debatable as another study concluded that
the level of pheomelanin increased in melanomic cells, when compared normal cells [108].
Zonio et al., therefore, concluded that the spectral responses are not strong enough to
obtain accurate melanin concentrations.
Hemoglobin
Hemoglobin is a type of protein and is vital to humans as it transports oxygen from respi-
ratory organs to other organs and the rest of the body. Hemoglobin is located in the red
blood cells, and the transportation of oxygen by hemoglobin is done via blood vessels. As
aforementioned, blood runs through the dermal layers in smaller vessels for the papillary
dermis and larger vessels for the reticular dermis. Normally, the hemoglobin concentration
in whole blood is between 134 and 173g/L [135], and the oxygenated hemoglobin, which is
the state with oxygen bound, can be as high as 95% in the arteries and as low as 47% in the
veins [4]. Once hemoglobin releases oxygen, it is called deoxygenated hemoglobin. Oxy-
genated and deoxygenated hemoglobin have different optical properties, and their responses
to melanoma are different as well. A study found that the concentration of oxygenated
hemoglobin is significantly lower for melanoma cases than that for benign cases, and conse-
quently, increased concentration of deoxygenated hemoglobin in melanomic cells [53]. This
phenomenon can explain hypoxia around the lesion, which is the condition of lower level
of oxygen in blood.
21
Other Features
While melanin and hemoglobin are the most important biomarkers for diagnosing melanoma,
other features such as bilirubin and β-carotene are also prevalent in blood or dermal layer,
respectively. Bilirubin is a brownish yellow pigment and provides a characteristic colour
to solid waste product. Although the limited studies are available for the relationship be-
tween the level of bilirubin in blood and melanoma, one study suggested that the increased
level of bilirubin may aggravate melanoma [17]. β-carotene is a red-orange pigment and a
pre-cursor to vitamin A, which plays important roles in vision and in maintaining normal
skin health. Like bilirubin, more thorough research needs to be conducted in order to
determine the relationship between melanoma and the given pigment, but it is believed
that β-carotene can be used to prevent cancer including skin cancer [120].
2.5 Summary
The chapter has presented background material to help understanding the remainder of
this thesis. The risk factors, staging, and treatment options of melanoma have been briefly
reviewed. Standard clinical procedures for detecting and diagnosing melanoma have been
reviewed. Furthermore, physiological biomarkers related to melanoma have been reviewed.
In the next chapter, we present a framework for extracting physiological biomarkers from
melanoma images for constructing a dermal radiomics sequence.
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Chapter 3
Physiological Biomarker Extraction
Model
In a dermal radiomics framework, physiological biomarker extraction is the first step for
constructing a dermal radiomics sequence. In this chapter, we review the existing physio-
logical biomarker extraction methods. Moreover, we propose a novel extraction technique
for eumelanin, pheomelanin, and hemoglobin from an acquired skin lesion image using a
non-linear random forest regression model.
3.1 Light-skin Interaction Model
To extract any desired physiological biomarkers from a skin lesion image, we first need
to understand how the colour of a skin lesion in the image is produced related to the
concentrations of physiological biomarkers. The relationship between them can be found
in light-skin interaction model. When light hits the surface of skin, the incident light
undergoes various interactions within skin, and finally reflected (Fig. 3.1). The light-skin
interaction model describes the behavior of light particles based on the optical properties
of skin pigments as well as interface between skin layers.
Modeling of light interaction with skin, which is multi-layered and inhomogeneous, is
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Figure 3.1: Illustration of how skin is colourized through light-skin interaction
a very complicated process, because the model has to take account of multiple scattering,
reflection, and absorption of light. The scattering of human skin can be divided into
two components: surface and subsurface scattering. Reflection is described by Fresnel
equations, and is affected by the presence of folds in the stratum corneum, which is the
most outer layer of skin. Approximately 5-7% of the incident light is reflected back to the
environment at the interface between air and stratum corneum. The remaining light is
transmitted into skin and two types of scattering occurs within the skin layers: Mie and
Rayleigh scattering. When light hits a particle, the type of scattering is determined by
the size of the particles related to the wavelength. Mie scattering is caused by particles
that are approximately the same size of the wavelength of light, and usually results in
forward scattering. The particles that are smaller than the size of the wavelength of light
are responsible for Rayleigh scattering. Light gets scattered multiple times inside each
layer before it is either propagated to another layer or absorbed. Absorption of light
at a particular wavelength is determined by skin pigments such as melanin, hemoglobin,
bilirubin and β-carotene, and absorbed light is converted to heat or radiated in the form
of fluorescence.
24
To implement these interactions under the skin, several light-skin interaction models
have been proposed based on Kubelka-Munk theory [26, 36, 43], diffusion theory [44, 48],
or Monte Carlo simulation algorithm [97, 73].
3.2 Existing Models
Extraction techniques of skin pigments are typically considered as an inverse model of
light-skin interaction model. Therefore, it is important to know how the forward model is
constructed for each extraction technique. In this section, we present several skin pigment
extraction models each with its corresponding forward model.
3.2.1 Erythema Index and Melanin Index
Erythema Index (EI) and Melanin Index (MI) were first introduced by Yamamoto et al.
in 2008 [134]. EI and MI are a quantitative measure of melanin and hemoglobin in the
epidermal and dermal layers of skin, respectively. This model simplified the light-skin in-
teraction model by considering only two skin pigments, which are melanin and hemoglobin,
and formulated the absorbance of this skin model using Lambert-Beer law [37, 124] as
Aλ = log(1/Rλ) = m(λ)Cm + h(λ)Ch +D (3.1)
where Rλ is the reflectance of the skin at λ, m(λ) and h(λ) are the extinction coefficients
of melanin and hemoglobin respectively, which measures how strongly each skin pigment
absorbs light at a given wavelength, Cm and Ch are the concentrations of melanin and
hemoglobin of the skin model, and D is the apparent absorbance of the dermis that is
constant. Let λ1 and λ2 be the two distinct wavelengths, and A1, A2, m(λ1), m(λ2),
h(λ1), h(λ2) are the absorbance and coefficient values at λ1 and λ2 respectively. The
difference between A1 and A2 can be written as
A1 − A2 = (m(λ1)− m(λ2))Cm + (h(λ1)− h(λ2))Ch (3.2)
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If λ1 and λ2 are chosen so that m(λ1)− m(λ2) is nearly zero or significantly smaller than
h(λ1)− h(λ2) and A1−A2, then combining Eq. (3.1) and Eq. (3.2) make a linear function
with respect to Ch and the difference between absorbances is the erythema index. The
melanin index is computed by making h(λ1)− h(λ2) nearly zero. For EI, λ1 is chosen at
a wavelength of 540-570 nm, where the ‘green band’ is located and λ2 is at around 660 nm
where the ‘red band’ is located. For MI, λ1 and λ2 are set at wavelengths of 620-650 nm
and 670-700nm respectively. Therefore, the formulation of EI and MI can be expressed as
following:
EI = log(1/Rgreen)− log(1/Rred) (3.3)
MI = log(1/Rred) (3.4)
where Rgreen and Rred are the reflectance of the skin at 540 nm and 660 nm, respec-
tively. Although EI and MI hold great linearity with the concentrations of hemoglobin and
melanin, different camera settings or illumination settings may change the indices greatly.
Moreover, EI and MI do not provide the absolute concentrations of features, rather the
relative concentrations.
3.2.2 Linear Light-skin Interaction Modeling
Linear light-skin interaction modeling (LLM) was proposed by Gong and Desvignes [55].
LLM computes concentration of melanin, total hemoglobin, and oxyhemoglobin (cMel,
cHb, and cHbO2 , respectively) by first constructing linear light-skin interaction model as
following:
 log(1/R(λr))log(1/R(λg))
log(1/R(λb))
 =
 HbO2(λr) Hb(λr) Mel(λr)HbO2(λg) Hb(λg) Mel(λg)
HbO2(λb) Hb(λb) Mel(λb)

 cHbO2cHb
cMel
 (3.5)
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where HbO2(λ), Hb(λ) and Mel(λ) are the tabulated extinction coefficients of oxygenated
hemoglobin, total hemoglobin and melanin [109, 140], and λr, λg, and λb are selected at
600nm, 540nm and 440nm, respectively.
As Eq. 3.5 was set up as linear equation, the concentration of melanin, total hemoglobin
and oxygenated hemoglobin can be inferred as an inverse model of Eq. 3.5 :
 cHbO2cHb
cMel
 =
 HbO2(λr) Hb(λr) Mel(λr)HbO2(λg) Hb(λg) Mel(λg)
HbO2(λb) Hb(λb) Mel(λb)

−1  log(1/R(λr))log(1/R(λg))
log(1/R(λb))
 (3.6)
While LLM is easy to implement and computationally efficient, the major limitation is
that the model oversimplifies the light-skin interaction. As discussed in Section 3.1, this
model only accounts for absorbance, and other light-skin interactions such as scattering
and reflectance are omitted. This model also ignores skin pigments except melanin and
hemoglobin, and does not account for all skin layers as it only considers epidermis and
dermis layers, in which melanin and hemoglobin are distributed.
3.2.3 Nearest Neighbor Model
Cavalcanti et al. [29] proposed a nearest neighbor model (NN) that extracts eumelanin
and pheomelanin concentrations from the standard camera image. To accomplish this, a
non-linear forward model was first constructed using a biophysically-based spectral model
of light-skin interaction [73], which models the way light within the visible spectrum prop-
agates in skin tissue to determine the reflectance spectra being observed by the camera.
Based on this forward model, a look-up table was constructed containing 1065 skin colours,
corresponding to various permutations of eumelanin and pheomelanin concentrations rang-
ing from 20 to 300 g/L, and from 8 to 60 g/L, with the steps of 4 g/L, respectively.
For the estimation of physiological biomarkers, an inverse model is constructed using a
nearest neighbor model. The colour of the testing sample is first matched to the colours
in the look-up table, which has the shortest squared Euclidean distance in RGB colour
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space to the testing sample, the corresponding eumelanin and pheomelanin concentrations
is obtained for the estimation.
While NN adopts a complex forward model for physiological biomarker estimation, NN
has a couple of limitations on performing this task. First, the possible estimation is limited
to 71 values, and 14 values for the eumelanin and pheomelanin, respectively. Second, due
to the nature of nearest neighbor model, the algorithm has to perform an exhaustive search
on a look-up table for each estimation, which may increase computational complexity.
3.3 Proposed Random Forest Model
In this section, a novel non-linear random forest regression model for extracting physio-
logical biomarkers from dermatological images is described. The proposed computational
model is designed to overcome the limitations of existing models in the literature, by
enabling the modeling of complex, non-linear light-skin interactions (MI/EI and LLM)
while maintaining greater flexibility and reduced computational complexity (NN). First,
the proposed non-linear light-skin interaction model is constructed as the forward model
(Section 3.3.1). Second, the proposed random forest inverse light-skin interaction model
and how it is learned is then described in detail (Section 3.3.2).
3.3.1 Non-linear, Forward Light-skin Interaction Model
As described by the LLM and NN models, the physiological biomarker extraction technique
can be considered as solving an inverse problem of light-skin interaction model. Therefore, a
non-linear light-skin interaction is first proposed as a forward model with input parameters
as concentrations of eumelanin, pheomelanin, and hemoglobin, and outputs as intensity
values in different colour spaces, including RGB. The proposed forward model is composed
of two parts. The first part is the computational light-skin interaction model, which was
proposed by Baranoski and Krishnaswamy [15, 72], and the second part is a tristimulus
value calculation, which generates 14 intensity values from five different colour spaces. The
visual illustration of the proposed forward model is shown in Fig. 3.2.
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Figure 3.2: Illustration of the proposed forward model
Computational Light-skin Interaction Model
The computational light-skin interaction model accounts for a total of five skin layers: 1)
stratum corneum, 2) epidermis, 3) papillary dermis, 4) reticular dermis, and 5) hypodermis.
At each interface, the proposed forward model characterizes the complex, non-linear, light-
skin interactions of reflection, surface/subsurface scattering and absorption, from which
reflectance spectra can be obtained.
The surface and subsurface reflection/transmission at the interface is determined based
on the Fresnel equation [121], which indicates how much light is reflected and transmitted
at a plane surface. The angle of reflection and refraction for the incident light can be
calculated based on the refractive indices of two skin layers for the given interface.
The surface scattering between air and stratum corneum varies according to the aspect
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ratio of the stratum corneum folds, which is represented as ellipsoids in this model. The
aspect ratio (σ ∈ [0, 1]) of the stratum corneum folds is defined as the quotient of the
length of the vertical axis by the length of the horizontal axis, which are parallel and
perpendicular to the specimen’s normal respectively. As the folds become flatter (lower σ),
the reflected light becomes less diffuse. To account for this effect, the model employed a
surface-structure function, which represents rough air-material interfaces using microareas
randomly curved [127]. The scattering is determined in terms of the polar angle given by :
α = arccos
[
((
σ2√
σ4 − σ4s+ s − 1)
1
σ2 − 1)
1/2
]
(3.7)
where s is the irregularity of surface of stratum corneum. For a ray that enters the epi-
dermis, the scattering is determined using azimuthal (β) and the polar angles where β is
ranged between 0 and 2pi, and the polar scattering angles measured by [26]. Every ray en-
tering dermis layer is tested for Rayleigh scattering. For the testing, the spectral Rayleigh
scattering amount, S(λ), is calculated as following:
S(λ) =
8tpi3((
ηf
ηm
)2 − 1)2
0.63cosθ(4
3
r3pi)−1λ4
(3.8)
where ηf is index of refraction of the fibers, ηm is index of refraction of the dermal medium,
t is the thickness of the medium, θ is the angle between the ray direction and the specimen’s
normal direction, and r is radius of collagen fibrils. The ray is scattered with a probability
of 1− exp−S(λ).
Once a ray has been scattered, it is tested for absorption. The absorption testing is
performed every time a ray enters into a new layer. For the testing, the ray free path
length based on Beer’s law [129] was calculated as following:
p(λ) = −Acosθ
µai(λ)
(3.9)
where A is the absorbance of a given layer, θ is the angle between the ray and the spec-
imen’s normal, and µai(λ) is the total absorption coefficient of a given layer, i. Total
absorption coefficient for each layer is obtained by multiplying the spectral extinction coef-
ficient of the pigment by its estimated concentration in the layer. Eumelanin, pheomelanin,
30
oxyhemoglobin, deoxyhemoglobin, bilirubin and β-carotene are taken into account in this
model. If p(λ) is greater than the thickness of the given layer, then the ray is propagated,
otherwise it is absorbed.
Tristimulus Value Computation
From this computational light-skin interaction model, the reflectance spectra, R(λ), is
collected, and is further processed to calculate outputs of the forward model, which are
the intensity values from 14 individual channels of RGB, XYZ, L*a*b*, L*u*v*, and xyz
colour space.
While the RGB spectral bands are used to define colour in a standard camera image,
the mapping from the reflectance values to RGB colour space involves an intermediate
step, which is the colour tristimulus values, XYZ. XYZ colour space was first introduced
by the International Commission on Illumination (CIE) in 1931 to describe the colour
space mathematically. This colour space was derived from the RGB model and expanded
beyond the RGB colour space. The XYZ can be calculated by the additive law of colour
matching [77].
X = N
∑
λ
R(λ)S(λ)x(λ)∆λ, (3.10)
Y = N
∑
λ
R(λ)S(λ)y(λ)∆λ, (3.11)
Z = N
∑
λ
R(λ)S(λ)z(λ)∆λ, (3.12)
where S(λ) is the relative spectral power distribution of the illuminant; R(λ) is the
reflectance function, which were modeled from the computational light-skin interaction
model; x(λ), y(λ) and z(λ) are the spectral sensitivity functions, and ∆λ is the wavelength
interval. For our experiment, CIE standard Illuminant D65 was used for S(λ), and the
CIE 1931 sensitivity functions of the standard observer for 2◦ and ∆λ = 5nm were em-
ployed for the spectral sensitivity function, x(λ), y(λ) and z(λ), and wavelength intervals,
respectively. The constant N was defined as
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N =
∑
λ
S(λ)y(λ)∆λ (3.13)
Once tristimulus values XYZ are obtained, they are converted to the RGB, L*a*b*,
L*u*v*, and xyz colour spaces. While the colour is conventionally defined in RGB colour
space, the forward model extends into a total of five colour spaces to define each colour,
which is created based on light-skin interaction model. The main reason for this extension
is that using three colour channels from RGB may not be sufficient to generate an accurate
inverse model. As each color space has an unique representation of the color, generating
14 colour channels in forward model eventually leads to more robust construction of its
inverse model. The detail of colour conversion from XYZ to other colour spaces can be
found in Appendix A.
3.3.2 Non-linear Random Forest Inverse Light-skin Interaction
Model
In the previous section, we presented a non-linear forward model, which uses concentration
of physiological biomarkers to generate intensities of 14 different colour channels as shown
in Fig. 3.2. This forward model uses non-linear light-skin interactions. To construct the
associated inverse model, which predicts the concentration of physiological biomarkers from
14 colour channels, random forest regression is employed.
Random forest is an ensemble learning technique for classification and regression that
works by constructing a large number of decision trees [24]. This technique was introduced
by Breiman[24], and is widely used in machine learning problems. Important components
of random forest are the bagging technique and the construction of a decision tree. In the
next section, decision tree learning and bagging technique are explained to understand the
random forest model.
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Decision Tree Learning
A decision tree is a machine learning technique to predict a label in class variable from
predictor variables using a binary tree. Given that Xi for i = 1, 2, ...k, is a set of predictor
variables, and Y is its corresponding class variable, decision tree is growing as following:
1. Start at the root node
2. At each node, find a subset of X based on an attribute value test (i.e., minimizing
the sum of Gini indexes). Use the subset to split the node into two child nodes.
3. Repeat step 2 for each child node until the splitting does not add any values to the
prediction, or the predetermined threshold is reached.
In a decision tree, each internal node, which has its’ child nodes, is typically labeled
with a single predictor variable, and each leaf, which does not have child nodes, is labeled
with a class.
Bagging
Bagging or bootstrap aggregating is a classification method, which uses multiple learning
classifiers (i.e., decision tree) for prediction. This technique is designed to improve the
stability and accuracy by avoiding overfitting, which is the common problem in decision
trees.
Given a training set of Si for i = 1, 2, ..., n, the bagging algorithm trains the classifiers
as following:
1. Generate a net set, S ′, by randomly sampling n samples with replacement from the
original training set, S.
2. Train a classifier (i.e., decision tree) based on the new set, S ′.
3. Repeat Step 1-2 t times
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After the training stage, bagging produces t number of classifiers. For each test example,
t classifiers are fitted and the results of all t trees are averaged for a final prediction value
for regression.
From bagging to random forest
While random forest and bagging generates many decision trees to aggregate the result,
the main difference between bagging and random forest is how each decision tree grows.
In bagging, all of predictor variables are considered for splitting at each interior node. In
random forest, only a subset of predictor variables are responsible for splitting at each node,
and the subsets are chosen randomly from the predictor variables. The default value for
the number of a subset at each node, mtry, is
√
k for classification and k/3 for regression,
where k is a total number of predictor variables. Therefore, bagging can be viewed as
a special case of random forest with mtry = k. The main reason of bringing additional
randomization into the random forest algorithm is to reduce variance to improve accuracy.
Since random forest is constructed based on decision trees, it is always exposed to a problem
of high variance. Because random forest introduces randomness for growing a decision tree
as well as sampling the training set, it can effectively offset the problem of high variance
without sacrificing low bias.
Training of the proposed random forest inverse model
For our inverse model, the concentration of eumelanin, pheomelanin, and hemoglobin is
predicted by individual random forest regression model. To train each model, the training
data is constructed using the proposed non-linear light-skin interaction forward model. The
input variables, which are the concentration of eumelanin, pheomelanin, and hemoglobin,
are varied from 50 g/L to 350 g/L for eumelanin, from 8 g/L to 92 g/L for pheomelanin,
and from 120 g/L to 188 g/L for hemoglobin, with the steps of 4 g/L. Other parameters for
the forward model are set to default values. The proposed non-linear light-skin interaction
forward model then generates the reflectance spectra via Monte-Carlo light propagation
simulation [72], where the light propagation is simulated as a random walk process using ray
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Figure 3.3: Visual representation of the original sample set. The concentration of eume-
lanin and pheomelanin is varied from 50 g/L to 350 g/L, and 8 g/L to 92 g/L, respectively,
while the concentration of hemoglobin is fixed at 120 g/L.
optics. As a result, we have collected a total of 30096 samples for training data, and each
sample consists of combination of eumelanin, pheomelanin, and hemoglobin concentration
as input, and its corresponding 14 intensity values from five colour spaces as output. The
visual representation is shown in Fig. 3.3. The image is the concentration map in RGB
colour space in which the eumelanin and pheomelanin concentrations varies while the
concentration of hemoglobin is fixed at 120 g/L.
Given that the training dataset,S, is generated, the random forest inverse light-skin
interaction model is trained as following:
1. A new set of samples, S ′, is constructed using bootstrap method from the original
sample set S.
2. A decision tree based on S ′ is generated.
3. At each interior node in the tree, a subset of mtry number of variables, which are
randomly chosen from predictor variables is selected, and the node using only the
subset of predictor variables is split.
4. The step 1 - 3 are repeated for n number of times.
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5. Overall prediction by averaging response (regression) or by choosing majority vote
(classification) are determined based on ntree number of individually trained trees
The number of subset of predictors, mtry, was set to five, and the number of decision
tree generated for each random forest model, ntree, was set to default value, which is 500
trees [24].
Figure 3.4: Illustration of random forest model which predicts concentration maps of eu-
melanin, pheomelanin, and hemoglobin from a skin lesion image
Extraction of physiological biomarker using random forest inverse model
Given that random forest inverse model is constructed for eumelanin, pheomelanin, and
hemoglobin, the concentration of the physiological biomarkers is extracted from a new skin
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lesion image as following:
1. From a skin lesion image, each pixel is treated as an individual sample, and RGB
intensity values at each sample are processed to generate 14 predictor variables based
on the conversion equation in Appendix A.
2. The random forest inverse model of eumelanin, pheomelanin, and hemoglobin is
employed to each sample.
3. For each sample, the concentration of eumelanin, pheomelanin, and hemoglobin is
predicted.
The visual representation of extraction of physiological biomarker is shown in Fig. 3.4.
3.4 Summary
In this chapter, we discussed light-skin interaction model, which is treated as a forward
model to extract physiological biomakrers. To develop physiological biomarker extraction
model, we implemented computational light-skin interaction model and extended it so
the forward model takes the concentration of eumelanin, pheomelanin, and hemoglobin
as input variables, and computes 14 intensity values from five different colour spaces as
outputs. Then, the novel physiological biomarker extraction technique was proposed as an
inverse model of light-skin interaction model. In the next chapter, the experimental design
and the results are reported for the proposed physiological extraction technique.
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Chapter 4
Experimental Results For
Physiological Biomarker Extraction
In the previous chapter, the novel physiological feature extraction technique for eumelanin,
pheomelanin, and hemoglobin was presented. This chapter presents a series of validation
experiments to examine how the proposed method performs compared to existing tech-
niques.
4.1 Testing Algorithms
In this validation study, five existing methods, including MI/EI, LLM, NN, AdaBoost
and bagging, are employed to compare with the proposed random forest regression model
for physiological biomarker extraction. The first three methods (MI/EI, LLM, and NN)
were described in Section 3.2, and two additional techniques are included for compari-
son. Although bagging and AdaBoost have not been adapted into physiological biomarker
extraction to the best to our knowledge, both are categorized as the ensemble learning
technique in which the proposed random forest model is. Therefore, AdaBoost and bag-
ging will provide a good comparison how the proposed method performs compared to its
similar algorithms. Moreover, the LLM can not distinguish eumelanin and hemoglobin,
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and NN by design extracts eumelanin and pheomelanin only. Therefore, we made some
modifications on LMM and NN for better comparison.
4.1.1 Linear Light-skin Interaction Modeling
In the original algorithm in Section 3.2.2, the mixing matrix, A, is constructed as follow
to extract eumelanin, hemoglobin, and oxygenated hemoglobin.
A =
 HbO2(λr) Hb(λr) Mel(λr)HbO2(λg) Hb(λg) Mel(λg)
HbO2(λb) Hb(λb) Mel(λb)
 (4.1)
However, in our validation, we do not employ the oxygenated hemoglobin as a biomarker,
but pheomelanin. Therefore, we updated the mixing matrix by replacing hemoglobin with
pheomelanin and the light-skin interaction forward model (Eq. 3.5) is modified as following:
 −log(r)−log(g)
−log(b)
 =
 EuMel(λr) PhMel(λr) Hb(λr)EuMel(λg) PhMel(λg) Hb(λg)
EuMel(λb) PhMel(λb) Hb(λb)

 cEuMelcPhMel
cHb
 (4.2)
where PhMel(λ) is the extinction coefficients of pheomelanin, which is obtained from the
study conducted by Sarna and Sealy [109].
4.1.2 Cavalcanti’s Nearest Neighbor Model
The look-up table, used by the original NN algorithm [29], contains 1065 skin colours
that are obtained from their forward model based on the permutation of 71 eumelanin
values and 15 pheomelanin values. This look-up table, however, is missing the hemoglobin
component. Here, the look-up table is made more comprehensive by augmenting it with the
hemoglobin component using the light-skin interaction model described in Section 3.3.2.
The improved look-up table contains a total of 30096 skin colours, that corresponds to
various permutation of the concentrations of eumelanin, pheomelanin, and hemoglobin.
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4.1.3 Ensemble Techniques
As the proposed random forest inverse model is an ensemble learning technique, we im-
plemented two other ensemble regression models, which are bagging and AdaBoost, for
comparison.
Bagging
Bagging(BA) is similar to random forest model in a way that both generate a large number
of decision trees to draw a result. However, for growing a decision tree, all predictor
variables are considered for splitting at each interior node in bagging. In random forest,
only a subset of predictor variables is responsible for splitting at each node, and the subset
are chosen randomly from the predictor variables. As a result, bagging can be viewed as a
special case of random forest to use all predictor variables for splitting instead of a subset
of predictor.
AdaBoost
AdaBoost(AB) is an ensemble learning technique that uses multiple classifiers to aggregate
a result. However, while random forest trains a classifier based on a training set, which is
generated by bootstrapping, each classifier in AdaBoost is trained on a training set, which
is weighted based on the performance of the previous classifier. The weight is increased on
the training sample, which was misclassified by the previous classifier, and decreased with
correctly classified. At each iteration, AdaBoost picks one classifier with the lowest cost
(error).
In this study, AdaBoost is adapted from a commercial software package (MATLAB2011a,
The MathWorks Inc., Natick, MA), and the same training set, which was used for the pro-
posed method are employed for both bagging and AdaBoost methods.
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4.2 Experimental Design
Since the ground truth concentrations of the physiological biomarkers are not available from
clinical images, the validation should be based on the synthetic dataset, which is generated
using the proposed non-linear, forward light-skin interaction model. Given this fact, three
different validation studies were conducted for the proposed method: 1) cross-validation
study, 2) skin lesion simulation study, and 3) separability test. Among the existing ex-
traction methods, MI/EI, LLM is builted based on linear light-skin interaction model, and
thus, the concentrations extracted from these models do not provide fair comparison to the
ones from the proposed non-linear model. For this reason, the mentioned three techniques
were tested only in skin lesion simulation study to provide visual comparison with other
techniques. For all non-linear extraction models including NN, AB, BA, they participated
in all three validation studies.
Figure 4.1: 10-fold cross validation results for the random forest regression (RF), the
Cavalcanti’s nearest neighbor model (NN), AdaBoost (AB), and bagging(BA). Error bars
indicate the 95% confidence intervals based on the Students T distribution
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4.2.1 Cross Validation
From the non-linear, forward light-skin interaction model using different permutations of
physiological features, a total of 30096 samples were collected. The training data were
randomly selected from 90% of the samples, and the accuracies were calculated from the
remaining 10% of testing data. The random selection and testing was repeated 10 times,
and the average root mean squared error (RMSE) was computed as a measure of accuracy.
The results from the cross validation are presented in Fig. 4.1.
4.2.2 Skin Lesion Simulation Study
To investigate the proposed algorithm in a more clinical setting, a simulation study, which
is based on clinical skin lesion images, was conducted. A chief limitation of using a clinical
skin lesion image in validation is that there is no known method to acquire the ground truth
concentrations of physiological features. To overcome this issue, a simulated image was
constructed based on a clinical image. While the extract concentration of the skin lesion
cannot be found, the simple ensemble technique (e.g. bagging) was employed to obtain the
estimated concentration map of physiological biomarkers for the simulated image. This
step ensures that the simulated image contains a realistic concentration map of eumelanin,
pheomelanin, and hemoglobin, which can be served as ground truth. To construct these
images, a clinical image of a malignant lesion was chosen and delineated. To assign the
concentrations of physiological features at each pixel, the following steps were taken.
1. A simple ensemble technique, trained only using RGB intensities as predictors, was
employed to estimate the initial concentrations for each physiological feature.
2. For each estimated concentration, randomly generated noise that ranges from −2 to
2 g\L was added.
3. Final concentrations of each physiological feature were recorded as ground truth.
A total of ten simulated images, consisting of seven malignant and three benign images,
were constructed and tested on RF, NN, AB and BA as well as MF and MI/EI. Similar to
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Figure 4.2: a) Simulated image was generated from a melanomic skin lesion image, and
the ground truth concentrations of each physiological feature were shown as concentration
maps: b) pheomelanin, c) eumelanin, and d) hemoglobin.
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Figure 4.3: RMSE from the predicted concentrations by RF, NN, AB and BA. Error bars
indicate the 95% confidence intervals based on the Students T distribution
the cross validation study, RMSE was computed for each case. The results are shown in
Fig. 4.3, and visual representation of eumelanin, pheomelanin, and hemoglobin are shown
in Figs. 4.4, 4.5, and 4.6, respectively.
4.2.3 Clinical Validation
For clinical validation, the separability test was conducted. The rationale behind conduct-
ing a separability test is that the physiological features are extracted to ultimately classify
malignant lesions against benign ones. The separability test measures the strength of each
feature to discriminate between the two classes (benign and malignant melanoma). Among
different classification algorithms, Fisher’s linear discriminant analysis (FDA) was chosen
[119]. The mathematical formulation of FDA is:
J(w) =
|m1 −m2|2
s21 + s
2
2
(4.3)
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Figure 4.4: a) Ground truth concentration of eumelanin in a simulated image was predicted
by b) RF, c) NN, d) AB, e) BA, f) MI/EI, and g) MF.
Figure 4.5: a) Ground truth concentration of pheomelanin in a simulated image was pre-
dicted by b) RF, c) NN, d) AB, e) BA, and f) MF.
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Figure 4.6: a) Ground truth concentration of hemoglobin in a simulated image was pre-
dicted by b) RF, c) NN, d) AB, e) BA, f) MI/EI, and g) MF.
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where m is mean, s is standard deviation, and the subscript represents a class. A dataset of
206 clinical images (119 melanoma, 87 non-melanoma) from DermIS [41] and DermQuest
[42] was gathered for this study, and RF, NN and AdaBoost were employed to extract
eumelanin, pheomelanin, and hemoglobin at each pixel of the segmented lesion in the
dataset. The concentrations at each pixel were treated as a sample and FDA was performed
for comparison. The results for the separability test is presented in Table 4.1.
Table 4.1: Comparing Fisher separability of eumelanin, pheomelanin and hemoglobin pre-
dicted using RF, NN and AdaBoost (AB).
Features Eumelanin Pheomelanin Hemoglobin
RF 0.1017 0.0854 0.0258
NN 0.0594 0.0025 0.0032
AB 0.0771 0.0143 0.0219
BA 0.0840 0.0096 0.0063
4.3 Discussion
While most existing skin feature extraction techniques are based on the surface of the
lesion and analyze the appearance of it, such as colour variation, or asymmetry of lesion,
the proposed approach utilizes sub-dermal skin information, which is not normally available
to clinicians or dermatologists. The extracted features provide additional information for
diagnosing melanoma, and may lead to an improved accuracy of diagnosis.
First, the cross validation was conducted to examine the performance of the proposed
algorithm with the synthetic data. The results show that the proposed random forest
algorithm outperformed NN and AdaBoost by a huge margin in eumelanin, pheomelanin
and hemoglobin as shown in Fig. 4.1. The bagging technique, which is a special case
of random forest algorithm performed well. However, the proposed model yielded more
accurate results in most cases (RMSE from RF yielded 2.75 g/L, 0.97 g/L, 1.41 g/L, and
bagging yielded 2.72 g/L, 1.14 g/L, 1.14 g/L for pheomelanin, eumelanin, and hemoglobin,
respectively), which implies that the proposed method is the most robust algorithm. The
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statistical significant testing was performed between testing algorithms and showed that
the results obtained from the proposed method are statistically significant as shown in
Table 4.2.
Table 4.2: Two-sample t-test between the proposed physiological biomarker extraction
technique and the existing extraction methods
p-value Eumelanin Pheomelanin Hemoglobin
NN <0.001 <0.001 <0.001
AB <0.001 <0.001 <0.001
Bagging <0.001 0.185 0.019
Second, the skin lesion simulation study was conducted. A simulated image was created
to mimic actual skin lesions with known concentrations of physiological biomarkers. A total
of ten simulated images were generated and tested. In the results, the proposed method
showed the superior performance over other methods in all of physiological biomarkers.
The simulated images consists of seven malignant and three benign images. Since the skin
lesion simulation study is the closest to the clinical setting with the ground truth, we can
infer that the proposed method can perform well not only malignant cases but also benign
cases.
Last, the separability test and malignant melanoma classification were performed as
clinical validation. The separability test is designed to examine the accuracy and the
robustness of each testing algorithm when performing on clinical lesions. To bypass the
problem that the exact concentrations of each biomarkers on skin lesion is not available
in clinical image dataset, a linear separability test (i.e., Fisher’s linear discriminant) was
employed. The corresponding concentration on every pixel of lesion was treated as a sam-
ple, and all of the samples were aggregated and underwent Fisher’s linear discriminant for
each biomarker. The Fisher separability shows the ability of each biomarker to differen-
tiate benign and malignant lesion. As shown in Table 4.1, the biomarkers extracted from
the proposed method outperform over the ones from NN and AB. Although these results
do not provide direct comparison on the feature extraction accuracy, the results certainly
infer the performance of each algorithm when dealing with actual clinical lesions, which
the proposed method is preferable.
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4.4 Summary
In this chapter, we conducted several validation studies to examine the performance of
proposed non-linear random forest inverse light-skin interaction model. A total of five
existing methods (MI/EI, LMM, NN, AB, and BA) were employed for the validation. and
the proposed method showed the superior accuracy on predicting physiological biomarkers.
In the next chapter, we construct the dermal radiomics sequence based on the extracted
physiological biomarker information.
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Chapter 5
Dermal Radiomics Sequence
5.1 Introduction
As aforementioned in Chapter 1, radiomics is a new cancer diagnostic tool that centers
around the high throughput extraction of quantitative features from medical images to
quantify tumor phenotypes. A radiomics sequence is a set of quantitative features, which
are extracted using different data-characterization algorithms. In dermal radiomics, the
original skin lesion images as well as their corresponding concentration maps, which are
generated by the proposed method in Chapter 3, are utilized for feature extraction. As a
result, a dermal radiomics sequence consists of four different sub-feature sets as illustrated
in Fig. 5.1: i) low-level feature set (LLF), ii) high-level intuitive feature set (HLIF), iii)
physiological feature set (PF), and iv) physiological texture feature set (PTF). While the
first two sets are adapted from the existing techniques [28, 3], the last two are novel feature
sets, which are based on the physiological biomarkers of the skin lesion. In the following
section, construction of each feature set is explained.
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Figure 5.1: Detailed block diagram of the proposed dermal radiomics sequence.
5.2 Existing Dermal Radiomics Feature Set
5.2.1 Low Level Feature
Low level feature set (LLF) consists of a total of 52 features that are extracted based on
ABCD-rule. This set is originally proposed by Cavalcanti and Scharcanski [28], and it
quantifies ABCD-rule with simple mathematical formulations. LLF is adapted into dermal
radiomics sequence because it provides a thorough characterization of a skin lesion based
on asymmetry, border irregularity, colour variation and structural difference. The full list
of 52 features is shown below.
1. Features that describe the asymmetry of lesion.
• f1: The ratio between the lesion area and its convex hull area (solidity).
• f2: The ratio between the lesion area and its bounding box area (extent).
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• f3: Equivalent diameter.
• f4: Circularity.
• f5: The ratio between the principle axes.
• f6: The ratio between sides of a bounding box containing the lesion.
• f7: The ratio between the lesion perimeter and its area.
• f8: The difference between the areas in the lesion that are divided by the major
axis divided by the lesion area.
• f9: The difference between the areas in the lesion that are divided by the minor
axis divided by the lesion area.
• f10: The ratio of the areas divided by the major axis.
• f11: The ratio of the areas divided by the minor axis.
2. Features that describe the border irregularity of lesion
• f12−14: The average gradient magnitude of the pixels in the dilated lesion rim,
in each one of the three colour channels.
• f15−17: The variance of the gradient magnitude of the pixels in the dilated lesion
rim, in each one of the three colour channels.
• f18−20: Dividing the lesion into 8 symmetric regions and computing the average
gradient magnitudes across the dilated rim, in each of the three colour channels.
• f21−23: Dividing the lesion into 8 symmetric regions and computing the variance
of the gradient magnitudes across the dilated rim, in each of the three colour
channels.
3. Features that describe the colour variation of lesion
• f24−27: Maximum, minimum, mean and variance of the pixels intensities inside
the lesion segment in the colour variation channel.
• f28−39: Maximum, minimum, mean and variance of the pixels intensities inside
the lesion segment in each of the colour channels.
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• f40−42: Ratios between mean values of the three original colour channels.
• f43−48: A count of the pixels who match the six hues typically associated with
melanoma.
4. Features that describe the differential structure of lesion
• f49−52: The maximum, minimum, mean and variance of the pixels intensities
inside the lesion segment to represent the textural variation.
5.2.2 High-level Intuitive Feature
High-level intuitive feature set (HLIF) is a mathematical model to describe the ABCD-
rule with human-observable characteristics, which can be intuited in natural way [3]. HLIF
consists of ten features which are derived based on the asymmetry, the border irregularity
and the colour variation of lesion, like LLF. The main difference between LLF and HLIF
is, however, that the scores from HLIF can be interpreted by dermatologists or clinicians,
while LLF does not provide any clinically relevant information by themselves. Although
clinical relevance from each feature to melanoma is not absolutely necessary in radiomics
sequence, HLIF adds variety on lesion characterization along with LLF.
Details of HLIF is described below:
1. Features that describe the asymmetry of lesion.
• f1: Colour asymmetry score.
• f2: Structural asymmetry score.
2. Features that describe the border irregularity of lesion
• f3: Fine irregularity score.
• f4: Coarse irregularity score.
3. Features that describe the colour variation of lesion
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• f5: Reconstruction error between one-vs-two colour patches
• f6: Reconstruction error between one-vs-five colour patches
• f7: Mean difference between one-vs-five colour patches
• f8: Mean difference between two-vs-five colour patches
• f9: Colour signature difference between one-vs-two colour patches
• f10: Colour signature difference between two-vs-five colour patches
5.3 Proposed Dermal Radiomics Feature Set
In this section, two feature sets are proposed: physiological feature set and physiological
texture set. The main similarity between these two sets is that the construction is based
on the concentration maps of physiological biomarkers. While PF uses the concentration
map from RGB colour space, PTF utilizes up to five colour spaces. Each set is explained
below.
5.3.1 Physiological Feature
A physiological feature set (PF) characterizes how concentration of physiological biomark-
ers is related to melanoma. PF is composed of nine features, and each feature in PF
captures relevant information between physiological biomarkers and melanoma, which can
be conveyed to dermatologists in an intuitive manner. First six features describe the mean
and the variance of the different physiological biomarkers. As explained in Section 2.4.2,
it is known that the overall concentration level is increased for eumelanin and hemoglobin
if the lesion is malignant. Moreover, the variance of concentration in the lesion is expected
to increase because the cancer cell is not growing uniformly, resulting in colour and border
of lesion irregularity.
Last three features measures spatial heterogeneity. Spatial heterogeneity of physiologi-
cal biomarkers is the extension of colour variation in ABCD-rule. As the ABCD-rule states,
colour variation within the lesion is the important characteristic for diagnosing malignant
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melanoma. Since colour of the lesion is produced as the result of light-skin interaction of
skin pigments, the spatial heterogeneity provides how each biomarker is discrepant within
the lesion, which eventually contributes to the colour variation in the lesion. The process
to calculate spatial heterogeneity of physiological biomarkers is shown in the next section.
Spatial Heterogeneity of Physiological Biomarkers
Given a segmented concentration map of physiological biomarkers, the map was divided
into two by an initial axis of separation (AoS), which was set to the major axis. For both
sides of the AoS, k clusters were determined using k -means clustering.
Sθi = k -means(C
θ
i , k) (5.1)
where θ denotes the orientation of the AoS, Sθi ∈ Sθ1 , Sθ2 is the concentration clusters to
either side of the AoS, and Ci ∈ Cθ1 , Cθ2 is the concentration per pixel for both sides. These
k clusters on both sides were then used to compute the Earth mover’s distance (EMD)
[105]. The rationale behind calculating EMD is that the “distance” represents the amount
of work to transform the distribution from one side to the one of the other. In other words,
it shows the amount of spatial heterogeneity of physiological biomarker concentrations
between two sides of lesion. In order to have a uniform sampling of AoS, this formulation
was repeated over n equally-spaced orientations, and the feature was determined for the
maximum spatial heterogeneity. The final calculation of a quantitative feature of spatial
heterogeneity of physiological biomarkers, FSH , is:
FSH = max
θ
{
EMD(Sθ1 , S
θ
2)
}
(5.2)
Eq.5.2 was repeated for eumelanin, pheomelanin and hemoglobin concentrations. Fig. 2b)
to 2d) show examples of the eumelanin, pheomelanin, and hemoglobin maps with the axes
of separation.
Finally, all of the nine PF are presented below:
• f1: Mean eumelanin concentration of the lesion.
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Figure 5.2: From a) original clinical image of melanoma, an example of b) eumelanin, c)
pheomelanin, and d) hemoglobin concentration map is shown. The white line represents
the axis of separation that yields maximal spatial heterogeneity.
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• f2: Variance eumelanin concentration of the lesion.
• f3: Mean pheomelanin concentration of the lesion.
• f4: Variance pheomelanin concentration of the lesion.
• f5: Mean hemoglobin concentration of the lesion.
• f6: Variance pheomelanin concentration of the lesion.
• f7: Spatial heterogeneity of eumelanin concentration.
• f8: Spatial heterogeneity of pheomelanin concentration.
• f9: Spatial heterogeneity of hemoglobin concentration.
Figure 5.3: An example skin lesion image with delineated boundaries of outer region(green),
lesion(red), and inner region(blue)
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5.3.2 Physiological Texture Feature
While the physiological feature set utilizes the physiological biomarkers via basic statistical
functions and their spatial heterogeneity, the physiological texture set (PTF) characterizes
the difference between a lesion and its surrounding normal tissue. In the early stage of
melanoma, melanoma usually evolves horizontally, and eventually moves vertically as it
advances. Therefore, the composition of physiological biomarkers at the core of the lesion
may differ from the one at the edge. The goal of PTF is to characterize and quantify these
changes within the lesion.
In PTF, a skin lesion is first manually segmented. Then, the lesion is further delineated
as outer region and inner region to have a total of three distinct regions (outer region, lesion,
and inner lesion) as shown in Fig. 5.3. After segmentation, the skin lesion image, which is
originally acquired in RGB colour space, is converted into five different colour spaces (XYZ,
L*a*b*, L*u*v*, xyz, and rgb) using colour conversion equations presented in Appendix A.
The concentrations of eumelanin, pheomelanin, and hemoglobin are then extracted
from the six converted images. For the extraction of physiological biomarkers in different
colour spaces, the random forest models for each colour space are constructed. While the
RF model constructed in Chapter 3 uses all of 14 colour channels as predictor variables,
the RF models for individual colour space only uses its own colour channels as predictor
variables to predict eumelanin, pheomelanin, and hemoglobin concentration. For example,
the predictor variables for the RF model, that is constructed for XYZ colour space, are
X, Y, Z channels. The purpose of using different colour spaces, rather than remaining in
the conventional RGB space is to investigate the more diverse interaction between three
predefined regions, as shown in Fig. 5.4.
Once the concentrations are obtained in all six colour spaces, the physiological texture
features are collected in two-steps, which are adapted from [30]:
1. Two statistical features (mean and standard deviation) associated with these three
regions are calculated over from eumelanin, pheomelanin, and hemoglobin physio-
logical biomarkers extracted from six different colour spaces (RGB, XYZ, L*a*b*,
L*u*v*, xyz, and rgb).
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Figure 5.4: An example of concentration maps of eumelanin, pheomelanin, and hemoglobin,
which are extracted from six different colour spaces including RGB, XYZ, L*a*b*, L*u*v*,
rgb, and xyz.
2. The following ratios and differences between the three regions are calculated for each
statistical feature: i) outer region(O) / lesion (L), ii) O / inner region (I), iii) L / I,
iv) O - L, v) O - I, and vi) L - I.
As a result, a total of 324 features are generated as following:
• f1−18: 3 physiological biomarker concentration (eumelanin, pheomelanin, hemoglobin)
* 3 regions (O,L,I) * 2 statistics (mean, standard deviation).
• f19−36: same as f1−18 in XYZ colour space.
• f37−54: same as f1−18 in L*a*b* colour space.
• f55−72: same as f1−18 in L*u*v* colour space.
• f73−90: same as f1−18 in rgb colour space.
• f91−108: same as f1−18 in xyz colour space.
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• f109−144: 3 physiological biomarker concentration (eumelanin, pheomelanin, hemoglobin)
* 6 ratio and difference features (O/L, O/I, L/I, O-L, O-I, L-I) * 2 statistics (mean,
standard deviation).
• f145−180: same as f109−144 in XYZ colour space.
• f181−216: same as f109−144 in L*a*b* colour space.
• f217−252: same as f109−144 in L*u*v* colour space.
• f253−288: same as f109−144 in rgb colour space.
• f289−324: same as f109−144 in xyz colour space.
5.4 Generating Dermal Radiomics Sequence
Given a skin lesion image, the dermal radiomics sequence is constructed by combining
four composing feature sets including : LLF, HLIF, PF, and PTF as shown in Fig. 5.1.
The proposed dermal radiomics sequence is composed of 395 features, that characterize
a lesion by quantifying conventional ABCD-rule as well as utilizing the concentration of
physiological biomarkers such as eumelanin, pheomelanin and hemoglobin. Among 395
features, some have known clinical significance (i.e., HLIF, and spatial heterogeneity of
physiological biomarkers) but most of them do not. As an individual feature, it does not
provide any meaning for melanoma screening. However, radiomics by definition does not
require to have clinical significance from individual feature, but it focuses on optimizing
a large number of features using feature analysis to draw a diagnostic decision. Dermal
radiomics sequence is the group of features, which serves as a foundation to be further
optimized for better melanoma screening.
5.5 Experimental Setup
In this section, we conduct two validation studies, whose purposes are two-fold: 1) to
assess the proposed physiological feature sets in melanoma screening, and 2) to examine
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the dermal radiomics sequence, compared to its composing four feature sets.
5.5.1 Data
For the validation of the proposed dermal radiomics sequence, we constructed a dataset of
206 clinical images of skin lesion. These images are acquired using standard consumer-grade
cameras under unconstrained environmental conditions. The dataset comprises of 119 ma-
lignant melanoma cases and 89 benign cases and all of images were extracted from publicly
available online databases: Dermatology Information System [41] and DermQuest [42].
5.5.2 Pre-processing
As the dataset was constructed under unconstrained environmental conditions, the illu-
mination as well as the size of the image varies from one to another. Therefore, in order
to minimize any errors occurred from the image acquisition, two-step pre-processing were
performed prior to the feature extraction
First, the illumination correction algorithm was applied. To correct various illumination
in the image, a model, which estimates a non-parametric illumination on the healthy skin
was generated using a Markov Chain Monte-Carlo (MCMC) approach. This model is then
used to create a quadratic surface from the non-uniform skin surface reflection, and finally
the light variation of the image is corrected by employing quadratic surface to the computed
reflectance map.
Second, the lesion is manually segmented and rotated so that the major axis of the
lesion is parallel to the horizontal axis. Next, 200 x 200 (pixel) bounding box was created
and the lesion was fitted into the box while maintaining the original aspect ratio. This
step ensures that every image in the dataset is rotation- and scale- invariant. The whole
process of pre-processing step is shown in Fig. 5.5
61
Figure 5.5: Pre-processing steps are taken as follow: a) original image, b) illumination
correction, c) cropping and rotation of a) to fit the lesion maximally, and d) manual
segmentation
5.5.3 Classification
To measure the ability to distinguish melanoma cases from benign using the proposed der-
mal radiomics sequence, a classification algorithm was employed. Classification is widely
used in machine-learning or pattern recognition field to assign a label to an image by eval-
uating the given feature vectors. In our problem, the labels are malignant melanoma or
benign, and the feature vectors are the proposed dermal radiomics sequences as well as other
testing feature sets. The classification used in this study is support-vector machine (SVM)
[35]. SVM is a supervised learning classification, in which the classifier is trained using the
known ground-truth in training data. Briefly, SVM tries to find (d − 1)-dimensional hy-
perplane from d-dimensional feature spaces so that any new point can be labeled regarded
to the hyperplane, which was created from the training data. SVM classifier is known to
be simple and robust, and thus, we employed linear SVM in our experiment.
Classification metrics used in this study are sensitivity, specificity and accuracy. Sen-
sitivity represents how correctly the classification can predict the malignant cases, and
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specificity represents how correctly the classification can predict the benign cases. Ac-
curacy measures all cases that are correctly predicted including malignant and benign.
Sensitivity, specificity, and accuracy can be formulated as following:
Sensitivity =
TP
TP + FN
(5.3)
Specificity =
TN
TN + FP
(5.4)
Accuracy =
TP + TN
TP + FP + TN + FN
(5.5)
where TP is true positive, TN is true negative, FP is false positive, and FN is false negative.
In this study, 80/20 cross validation is conducted for classification. Given that n samples
for the test, 80/20 cross validation randomly chooses 80% of n samples to be a testing data
and the remaining 20% becomes a testing data. In our experiment, 80/20 cross validation
is iterated for 50 times.
5.5.4 Validation Study on Proposed Physiological Feature Sets
From Section 5.2 and 5.3, four composing feature sets of the dermal radiomics sequence
were generated. For simplicity of discussion, the following notation for each feature set is
used throughout this section.
• SLLF : 52 Low level features
• SHLIF : 10 High level intuitive features
• SPF : 9 Physiological features
• SPTF : 324 Physiological texture features
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Now, we examine the proposed physiological feature sets. Since the existing feature sets
(SLLF and SHLIF ) are constructed to mathematically describe each criteria of ABCD-rule
such as asymmetry, border irregularity, and colour variation, the proposed physiological
features (SPF and SPTF ) are treated as ’criteria’ as well.
To do that, we combine SLLF and SHLIF together, and categorize them based on
asymmetry, border irregularity and colour variation. Entire SPF and SPTF are treated
as ’physiological biomarker’. Each set is defined as follows:
• FA : asymmetry - 13 features (f1−11 from LLF, and f1−2 from HLIF)
• FB : border irregularity - 14 features (f12−23 from LLF, and f3−4 from HLIF)
• FC : colour variation - 31 features (f24−48 from LLF, and f5−10 from HLIF)
• FPB : physiological biomarker - 333 features (f1−9 from PF, and 324 features from
PTF)
The 80/20 cross validation was conducted to perform and compare the classification
using a feature set of each criteria: FA, FB, FC , and FPB.
5.5.5 Validation Study on Dermal Radiomics Sequence
This validation is conducted to examine the classification accuracy of the dermal radiomics
sequence as whole. For comparison, the following feature models, which comprise of dif-
ferent permutations of SLLF , SHLIF , SPF , SPTF were constructed
• FLLF = SLLF
• FHLIF = SLLF ∪ SHLIF
• FPF = SLLF ∪ SHLIF ∪ SPF
• FDRS = SLLF ∪ SHLIF ∪ SPF ∪ SPTF
80/20 cross validation was conducted to perform and compare the classification using
each feature model, FLLF , FHLIF , FPF , and FDRS.
64
5.5.6 Results
Validation study on the proposed physiological feature sets
We examined the sensitivity, specificity, and accuracy of the proposed feature sets against
the feature sets that are categorized by ABCD-rule in Fig. 5.6.
Figure 5.6: Comparing classification results from FA, FB, FC , and FPB over 50 80/20
validation trials. Error bars indicate the 95% confidence intervals based on the Students
T distribution.
In 80/20 cross validation, the set describing physiological biomarker, FPB, showed
a superior performance on sensitivity, specificity, and accuracy with 79.6%, 67.8%, and
74.5%, respectively. For accuracy, the difference between FPB and FC is as high as 11%.
For this result, the number of features in each set might affect the outcome of classification
as FPB contains 333 features while FA, FB, and FC has 13, 14 and 31 features, respectively.
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However, despite the number of features in FC is more than double the number of features
in FA and FB, the accuracy of FC is lower than the one of FA and FB. Therefore, the
number of feature cannot solely explain the performance of classification and the proposed
feature sets have well characterized the lesion. Moreover, the proposed feature showed
more balanced performance while the existing feature sets suffer from low specificity even
with the high sensitivity. This result implies that the proposed feature set is robust, and
echoes with our hypothesis that utilizing physiological biomarker information can improve
the overall classification results.
Validation study on dermal radiomics sequence
The classification using FDRS was compared with the one using FLLF , FHLIF , and FPF ,
and the sensitivity, specificity and accuracy for 80/20 validation are shown in Fig. 5.7.
From the results of two validation tests, the proposed feature models showed the supe-
rior performance on correctly predicting malignant melanoma cases as well as benign ones.
FPF yielded the best accuracy with 75.8% for 80/20 validation, while FDRS is placed for the
second best results. Both of the proposed methods outperformed over the existing meth-
ods, which implies that adding physiological biomarker information into the melanoma
screening system can improve the diagnostic outcomes.
However, we also observed that FDRS continually underperformed compared to FPF . A
possible explanation on this result can be found from the number of feature space used as
the number of features in FPF is 71 while FDRS used a total of 395 features. Given that our
experiment has only a limited number of samples (i.e. 206 samples), the excessively high-
dimensional feature space for FDRS actually depress the predictive power (i.e. the curse of
dimensionality). This suggests that to improve the diagnostic outcome, the system requires
the feature selection algorithm to reduce the feature space. Optimizing FDRS is thoroughly
discussed in Chapter 6.
Lastly, we compared the results between FDRS and FPB from Fig. 5.7 and 5.6, which
are very similar (78.7% vs 79.6% for sensitivity, 66.6% vs 67.8% for sensitivity, and 73.5%
vs 74.5% for sensitivity, for FDRS and FFB, respectively.) FPB is composed of physiological
features only (SPF and SPTF ), and FDRS contains all four feature sets. The results that
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Figure 5.7: Comparing classification results from FLLF , FHLIF , FPF , and FDRS over 50
80/20 validation trials. Error bars indicate the 95% confidence intervals based on the
Students T distribution
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the difference between two models is very small implies that FPB heavily influences the
decision made by FDRS, and other feature sets (SLLF and SHLIF ) are mostly ignored or the
influence is minimal. This limitation becomes another reason that FDRS requires a proper
feature selection to improve the results, on top of the curse of dimensionality.
5.6 Summary
This chapter has presented the dermal radiomics sequence, which consists of the existing
feature sets based on ABCD-rule, and the novel feature sets. The proposed feature sets
extracted a total of 334 features, which utilizes the spatial heterogeneity as well as ex-
ploring different colour spaces to characterize the skin lesion better. The validation study
showed that the DRS can outperform over the existing sets with the improved results, but
at the same time, the challenge that incurred from the curse of dimensionality. In the
next chapter, we conduct feature analysis on the DRS by examining feature selection and
classification algorithm for improving diagnostic outcome of melanoma.
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Chapter 6
Feature Analysis for Dermal
Radiomics
6.1 Introduction
In the two previous chapters, the fundamental blocks of dermal radiomics framework have
been discussed. The roles of eumelanin, pheomelanin, and hemoglobin related to melanoma
were explored, and a novel technique to quantify their concentrations was proposed. Based
on these information, the dermal radiomics sequences, which characterizes each skin lesion
with unique 395 features, was designed. This current chapter presents a final process of
dermal radiomics, which is feature analysis. Feature analysis is divided into classifica-
tion analysis and feature selection analysis to find the feature selection and classification
algorithm that works the best with the proposed dermal radiomics sequence.
6.2 Classification Analysis
In this section, different classification algorithms are discussed to find an appropriate clas-
sification algorithm for the dermal radiomics framework. Three classification algorithms
have been examined: random forest classification (RF), support vector machine (SVM),
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and naive Bayes classification (NB). Random forest classification was a family of ensemble
learning algorithm, and thus, it is well known to handle well on highly non-linear interac-
tions from predictors. SVM and Bayesian classification is one of the most frequently used
classification algorithms for diagnosing melanoma, and have shown the promising results
in many studies [30, 45, 106, 29].
6.2.1 Experimental Design
For the dataset used in this experiment, a total of 206 pre-processed skin lesion images,
which were acquired by standard camera, was used. A detailed explanation of data collec-
tion and pre-processing step can be found in Section 5.5. In short, each skin lesion image
goes through dermal radiomics framework and eventually generates the dermal radiomics
sequence. Each image in the dataset is labeled either malignant or benign as the ground
truth for the classification. Then, the three classification algorithms (RF, SVM, NB) are
examined on the set of dermal radiomics sequence. For RF, the number of trees used for
classification, and the subset of predictor variables used at each node are set at the default
values, and for SVM, quadratic kernel was employed.
To get a comprehensive assessment of classification, an additional measure, which is the
receiver operating characteristic (ROC) curve, was used on top of sensitivity, specificity,
and accuracy. Using only sensitivity, specificity, and accuracy may conclude a biased
decision on highly disproportionate dataset of malignant and benign cases. ROC curve is
the visualization of the classifier’s ability to separate two classes regardless of the proportion
of classes. The ROC curve is a plot of true positive rate (sensitivity) versus false positive
rate (1-specificity) across varying cut-offs, and therefore, the accuracy is determined by
how close the curve follows to the upper-left border of the ROC space (Fig. 6.3).
To calculate the accuracy of each classification method, the leave-one-out cross valida-
tion (LOO) and 80/20 cross validation are employed. Given that n samples for the test,
LOO uses n−1 samples as training data, and the only remaining sample is used for testing.
It iterates n times so that every sample in the data could be used as testing data. 80/20
cross validation uses 80% of the entire dataset as training data, which is randomly chosen
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at each iteration, and the remaining 20% is used as testing data. In this validation study,
50 trials of 80/20 cross validation are performed.
Figure 6.1: 80/20 cross validation: The sensitivity, specificity, and accuracy of RF, SVM,
and NB classification are reported. Error bars indicate the 95% confidence intervals based
on the Students T distribution.
6.2.2 Results
Fig. 6.1 and 6.2 shows sensitivity, specificity and accuracy of all testing classification al-
gorithms, which was performed using the dermal radiomics sequence. From 80/20 cross
validation, RF outperformed over other methods by yielding 85.0% of sensitivity, 72.7% of
specificity, and 79.3% of accuracy. Similar trend was observed in the LOO cross validation
results. Moreover, from ROC curve shown in Fig. 6.3, RF (in blue) performs better than
SVM (in red) and NB (in green) in most of time, and the area under curve (AUC), which
measures the performance of ROC curve as a quantitative value, for RF, SVM and NB are
reported as 0.87, 0.83, and 0.75, respectively. From these results, it shows that RF is well
suited for dermal radiomics framework, and thus, RF classification algorithm are employed
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for further feature analysis process over SVM and NB. The findings are statistically signif-
icant based on the two-sample t-test between RF and other two classification algorithms
(SVM and NB) in Table 6.1.
Table 6.1: Two-sample t-test between RF classification, SVM and NB.
p-value Sensitivity Specificity Accuracy
SVM <0.001 <0.001 <0.001
NB <0.001 <0.001 <0.001
Figure 6.2: Leave-one-out cross validation: The sensitivity, specificity, and accuracy of RF,
SVM, and NB classification are reported. Error bars indicate the 95% confidence intervals
based on the Students T distribution.
6.2.3 Parametrization of Random Forest Classification
Given that random forest classification is chosen for further feature analysis, two main
parameters of random forest should be determined, which are mtry, and ntree. mtry repre-
sents the subset of predictor variables that are used for each node split, and mtry is chosen
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Figure 6.3: ROC for RF, SVM, and NB classification
randomly at the node. The default value for the number of mtry is
√
k for classification,
and k/3 for regression, where k is the number of entire predictor variables. ntree is the
number of classifier generated, and the default value is 500. In this section, mtry and ntree
are parametrized to optimize the performance of random forest for dermal radiomics.
Parametrization for mtry
For the search of mtry, three different values have been tested: 1)
√
k, 2) k/3, and 3) 6.
The value of six was chosen because the default value of mtry is six when top 10% rank
on DRS was used. Therefore, instead of varying mtry for different feature model, the value
was fixed as six for consistency. 50 80/20 validation trials were performed on DRS, and
the evaluation results were reported in Table 6.2.
As shown in Table. 6.2, the changes between different mtry are very small that any
choice of mtry would not influence the results greatly. However, some variation are found
in time executed between k/3 and other two that the choice of k/3 took longer to execute.
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Table 6.2: Evaluation results: the sensitivity, specificity, accuracy and execution time for
50 80/20 validation trials of RF classification by varying the value of mtry.
mtry Sensitivity (%) Specificity (%) Accuracy (%) Execution time (s)√
k 84.0 71.4 78.5 28.6
k/3 84.2 71.7 78.8 35.5
6 85.2 68.0 77.3 29.5
This is because the value of mtry at each node with k/3 is greater than other two and thus
takes longer to generate each tree. As a result, the proposed RF classification chose to use√
k, which is the default value, for the value of mtry.
Parametrization for ntree
For the optimal value for ntree, there are studies that recommend setting the value of ntree
under 200 [76, 87]. Therefore, five options for ntree have been examined: 1) 50, 2) 100, 3)
250, 4) 500, 5) 750. For the validation, the exact same setting with the one that used for
mtry was used, and the results are presented in Table 6.3.
Table 6.3: Evaluation results: the sensitivity, specificity, accuracy and execution time for
50 80/20 validation trials of RF classification by varying the value of ntree
ntree Sensitivity (%) Specificity (%) Accuracy (%) Execution time (s)
50 81.5 69.9 76.2 14.8
100 84.4 72.5 79.2 30.4
250 84.5 69.8 77.9 73.3
500 85.1 69.0 78.2 148.3
750 83.9 71.1 78.4 213.4
From Table 6.3, the choice of ntree does not have major impact on the results on
sensitivity, specificity, and accuracy, while using 100 tree yields a slight improvement on
accuracy. Moreover, classification with ntree = 100 is computationally efficient compared to
when the larger number of trees are used. To balance the accuracy and the computational
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complexity, the value of 100 was chosen for ntree.
6.3 Feature Selection Analysis
As discussed in the previous chapter, the dermal radiomics sequence has two limitations
to use as it is. First is because of its size, that is close to 400 features per image, it suffers
from the curse of dimensionality. Secondly, because the number of features from physio-
logical feature sets outnumbers the one from low level feature set and high level intuitive
feature set, the classification is heavily dependent on the former sets. To overcome these
limitations, a proper feature selection on the dermal radiomics sequence is an essential step
to improve overall accuracy of melanoma screening. In this section, three feature selec-
tion algorithms (ReliefF, random forest variable importance, and the maximum relevance,
minimum redundancy technique) ,that are implemented into the classification process, are
discussed.
6.3.1 ReliefF
ReliefF is a feature selection algorithm proposed by Kira and Rendell [66, 102]. ReliefF
evaluates a predictor according to how well it can distinguish between similar instances. A
predictor, that is able to separate similar instances with difference class earns more weight,
and a rank of each feature is determined by weight they earned. Mathematically, given
a training data set with n samples of p predictor variables, and a weight vector, Wi for
i = 1, 2, ..., p, the ReliefF estimates the quality of predictors as following:
1. Set all weights Wi = 0
2. Randomly select a sample, R, from the training data
3. Find k number of nearest neighbors from the same class, Hj, and from the different
class, Mj for j = 1, 2, ...k
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4. Update W such that
Wi = Wi− 1
m
[∑ dif(i, Rj, Hj)
k
+
∑ dif(i, Rj,Mj)
k
]
(6.1)
where i = 1, 2, ..., p and
dif(i, I1, I2) =
|value(i, I1)− value(i, I2)|
max(i)−min(i) (6.2)
5. Repeat Step 2 - 4 for m times
After W is calculated, the predictors are selected if Wi is greater than a pre-determined
threshold.
6.3.2 Random forest variable importance (RF-VI)
In random forest algorithm, variable importance can be calculated to measure how each
variable influences the tree generation [24]. This variable importance can be used as a
good metric for feature selection.
Variable importance in random forest algorithm is calculated using out-of-bag (OOB)
error estimation. OOB data is a group of samples that are left out as results of random
forest unique sampling. Since the new set is generated by randomly sampling the original
dataset with replacement, about one-third of original data is unused., This unused set is
called OOB, and is used to get estimates of variable importance. The variable importance
for a predictor, m, is calculated as following:
1. For every tree in the forest, test OOB cases and count the number of votes cast for
the correct class
2. Randomly permute the value of m in the OOB cases
3. Put down OOB cases in which the value of m is modified.
4. Subtract the number of votes for the correct class in Step 3 from the ones in Step 2.
5. Average of Step 4 for all trees in the forest is the importance score for variable m.
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6.3.3 Maximum Relevance, Minimum Redundancy Technique
The maximum relevance, minimum redundancy technique (mRMR) was introduced by
Peng et. al [94], and it find the feature which has maximal relevance and minimal redun-
dancy. Maximal relevance is a process of finding a feature with the highest relevance to
the target class, while minimal redundancy find a feature that maximize the joint depen-
dency of features on the target class to reduce redundancy among features. mRMR uses
a heuristic search algorithm to satisfy both maximal relevance and minimal redundancy.
Mathematically, relevance and redundancy of feature subset is defined as follows:
V (i, h) =
1
|F |
∑
i∈F
I(i, h) (6.3)
W (i) =
1
|F |2
∑
i,j∈F
I(i, j) (6.4)
where Fm is a feature subset, h is the target class, i, j is features, and I(·) is the mu-
tual information function. V and W are the relevance and redundancy of feature set,
respectively. The best feature subset, is found using greedy search algorithm to satisfy the
following criteria:
max Φ(V,W ), Φ = V −W (6.5)
6.3.4 Experimental Design
In this experiment, three features selection methods were validated: mRMR, ReliefF and
RF-VI. The experimental setup is exactly the same as the one used in classification analysis.
Each method runs through the training dataset and ranks each predictor variable from the
most influence one to the least. Then, random forest classification was employed on the
subset of dermal radiomics sequences, and the number of feature used increased from 5 to
385 with a step of 10. To measure the accuracy of the testing feature selection algorithms,
LOO cross validation and 50 trials of 80/20 cross validation were conducted.
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Figure 6.4: The sensitivity results of Leave-one-out cross validation using mRMR, ReliefF
and RF-VI as feature selection algorithms
Figure 6.5: The specificity results of Leave-one-out cross validation using mRMR, ReliefF
and RF-VI as feature selection algorithms
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Figure 6.6: The accuracy results of Leave-one-out cross validation using mRMR, ReliefF
and RF-VI as feature selection algorithms
6.3.5 Results
Fig. 6.4, 6.5, and 6.6 shows the sensitivity, specificity, and accuracy of the random forest
classification, which is coupled with feature selection algorithms. As expected, the use of
feature selection algorithm improved the overall results. For example, The use of ReliefF
improved its accuracy by 6.8%, compared to the accuracy when no feature selection method
was used. Moreover, when feature selection algorithm was loosely applied to use more
number of features, the results between three feature selection methods did not vary much.
However, the performance of each feature selection was more visible when less than 80
features were chosen for the classification. While ReliefF outperformed over other two
methods, mRMR showed the worst performance of all.
Table. 6.4 shows the quantitative results of the sensitivity, specificity and accuracy from
each feature selection model. The results were chosen by the best accuracy with the number
of features used. In 80/20 cross validation, ReliefF showed the excellent performance on
ranking features. The number of features for the best results is between 35 and 45, which is
about 10% of the entire dermal radiomics sequence. mRMR showed the worst performance
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of all three testing feature selection algorithms. The number of features used to yield the
best accuracy is 145, and mRMR did not work well on optimizng the DRS when compared
to ReliefF algorithm.
Table 6.4: 50 trials of 80/20 cross validation results for melanoma detection: Compar-
ing feature selection models (ReliefF, RF-VI and mRMR) on sensitivity, specificity, and
accuracy(%). Results are shown with 95% confidence interval.
Feature selection
method
Number of
features
Sensitivity Specificity Accuracy
ReliefF 35 88.8 [87.2 90.4] 77.9 [74.9 80.8] 84.1 [82.7 85.5]
RF-VI 75 85.8 [83.8 87.8] 72.9 [69.8 76.0] 80.2 [78.7 81.7]
mRMR 170 83.3 [81.4 85.3] 71.7 [68.9 74.5] 78.4 [76.7 80.1]
Another classification metric was used to examine the performance of feature selection
aglorithm. A receiver operating characteristic (ROC) curve was computed in Fig. 6.7. The
results from ROC curve also agree with our findings above as area under curve (AUC) for
ROC is 0.91, 0.88, and 0.85 for ReliefF, RF-VI, and mRMR, respectively.
Lastly, the ranked features are examined to see how each feature are contributed to
overall classification results. Among 35 highly ranked features by ReliefF feature selection
algorithm, 9 features are from low level feature set. More specifically, four of nine describes
asymmetry, three and two features describe color variation and differential structure of
lesion, respectively. Two features, which describes irregularity of lesion, are from high
level intuitive feature set. Moreover, mean and variance of eumelanin and hemoglobin
are ranked as the most important features from physiological feature set. Lastly, a total
of 20 features are highly ranked from physiological texture feature set for classification.
Nine, six, and five features are derived from eumelanin, Pheomelanin, and hemoglobin,
respectively.
Given that the majority of dermal radiomics sequence is made up by physiological
texture feature set, a 35 highly ranked features have well-balanced mixture of each fea-
ture set: 11 features are obtained from LLF and HLIF, and 24 are from PT and PTF. It
reflects that the proposed dermal radiomics, which is composed of the feature set based
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Figure 6.7: ROC for different feature selection methods
on both ABCD-rule and physiological biomarkers, improves the accuracy of melanoma
diagnosis, compared to the feature sets only based on ABCD-rule. Moreover, no domi-
nant physiological biomarker was observed as eumelanin, pheomelanin, and hemoglobin
equally contributed to the highly ranked features, which concludes that the selection of
physiological biomarkers was appropriate for the dermal radiomics.
In this section, a validation study was constructed to assess different feature selection
algorithms on dermal radiomics sequence. Among ReliefF, RF-VI, and mRMR, ReliefF
showed the superior performance on ranking dermal radiomics sequence to yield an excel-
lent classification result. Feature analysis tuned the dermal radiomics sequence by using
ReliefF to pick top 10% of its entire feature set and ultimately, the accuracy was improved
by as high as 6.8%, compared to when no feature selection model was employed. While
two other feature selection algorithm performed as good as ReliefF when a large number of
features used , which is more than 80. However, the classification metrics were decreased
when RF-VI and mRMR ranked fewer number of features for classification, which implies
that they failed to rank features effectively.
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6.4 Validation study on dermal radiomics
From the feature analysis, the random forest classification and reliefF were selected as the
classification and feature selection algorithm for dermal radiomics framework. To validate
the complete dermal radiomics, it was compared with the state-of-the-art computer-aided
melanoma diagnosis as well as the conventional diagnosis of dermatologists.
6.4.1 Comparison with the state-of-the-art techniques
Given that the proposed dermal radiomics use the standard camera imaging modality in-
stead of dermascopic images, the two state-of-the-art computer-aided melanoma screening
systems, which are also uses the dermal images, are chosen for comparison. The first
melanoma screening system was adapted from Cavalcanti et al. [28]. They designed fea-
tures which describes ABCD-rule using mathematical formulation, and the feature set they
designed are adapted into dermal radiomics sequence as low level feature. The next state-
of-the-art technique was developed by Amelard et. al. [3], and they constructed high level
intuitive features based on ABCD-rule as well. The melanoma screening for this group
was performed based on the feature set, which combined their novel features as well as low
level features. For the validation, 50 trials of 80/20 cross validation study was performed
on the proposed dermal radiomics sequence as well as two state-of-the-art techniques, and
the feature model for each technique is defined as follows:
• FLLF = SLLF
• FHLIF = SLLF ∪ SHLIF
• FDRS = SLLF ∪ SHLIF ∪ SPF ∪ SPTF
The sensitivity, specificity and accuracy of the state-of-the-art techniques as well as
proposed dermal radiomics, which are obtained from feature analysis, are presented in
Table 6.5. For comparison, the result table from Section 5.5.5 was adapted in Table 6.6.
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Table 6.5: 50 trials of 80/20 cross validation results from random forest classification,
which is coupled with ReliefF feature selection algorithm: Comparing feature models (LLF,
HLIF and DRS) on sensitivity, specificity, and accuracy (%). Results are shown with 95%
confidence interval.
Feature model
Number of
features
Sensitivity Specificity Accuracy
FLLF 25 86.4 [84.6 88.3] 69.5 [66.6 72.3] 79.3 [77.7 80.8]
FHLIF 30 88.2 [85.8 90.5] 73.3 [69.8 76.8] 81.5 [79.7 83.3]
FDRS 35 88.8 [87.2 90.4] 77.9 [74.9 80.8] 84.1 [82.7 85.5]
Table 6.6: 50 trials of 80/20 cross validation results from SVM classification, without fea-
ture selection algorithm: Comparing feature models (LLF, HLIF and DRS) on sensitivity,
specificity, and accuracy (%). Results are shown with 95% confidence interval.
Feature model Sensitivity Specificity Accuracy
FLLF 73.5 [70.9 76.2] 61.2 [58.0 64.5] 68.3 [66.7 70.0]
FHLIF 79.2 [76.8 81.7] 63.9 [59.9 67.9] 72.1 [69.9 74.3]
FDRS 79.0 [76.2 81.7] 65.5 [62.7 68.4] 73.2 [71.5 74.9]
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In Table 6.5 and 6.6, classification results were compared with/without feature analysis.
the proposed dermal radiomics sequence, FDRS, showed an inferior performance in Table
6.6 when the entire feature set was used for classification. However, the vast improvement
on all classification metrics including sensitivity, specificity and accuracy was observed with
the use of feature analysis. Moreover, not only the results from FDRS was improved but
also the results from all other feature models were increased when the appropriate feature
selection and classification algorithm were applied. From the statistical significant testing,
the superior performance of the proposed method are statistically significant on specificity
and accuracy (Table 6.7).
Table 6.7: Two-sample t-test between the dermal radiomics and the state-of-the-art tech-
niques.
p-value Sensitivity Specificity Accuracy
LLF 0.057 <0.001 <0.001
HLIF 0.656 0.045 0.022
6.4.2 Comparison with conventional diagnosis
The complete dermal radiomics was compared with the current diagnostic practice of der-
matologists. Given that it is not possible to compare the accuracy directly because no
diagnosis from dermatologists was made in the same setting in which the dataset was
collected, the sensitivity and specificity were compared based on the report from the lit-
erature. Two studies were found in terms of the melanoma diagnosis: 1) dermatologists
conducted diagnosis of melanoma in the clinical setting by directly contacting patients and
2) dermatologists diagnose based on the dermal images only. While the proposed dermal
radiomics exhibits 88.7% of sensitivity and 78.6% of specificity, dermatologists experience
71% of sensitivity and 81% of specificity when diagnosing on site [130] , and 98.1% of sen-
sitivity and 30.4% of specificity when diagnosing based on images [132]. The results shows
that the proposed method provides more reliable and robust diagnosis on melanoma. Espe-
cially, when dermatologists used the image only for making diagnostic decision, it yielded
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high sensitivity but the specificity was dismal. The balanced results from the dermal ra-
diomics make the proposed framework more suitable for a tele-medicine tool, for which the
diagnosis based on images is greatly appreciated.
6.5 Summary
This chapter has presented the random forest classification for dermal radiomics frame-
work. To optimize the performance of random forest classification, the parametrization
was conducted, and the feature selection algorithm was integrated into the classification.
Moreover, a series of validation study was conducted to assess the proposed dermal ra-
diomics sequence and the classification algorithm against the existing ones. The results
showed that the random forest using DRS can yield superior performance, which implies
that the proposed dermal radiomics can aid dermatologists and general practitioners to
improve their melanoma diagnostic outcomes.
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Chapter 7
Conclusions
In this chapter, the summary of research contributions is provided followed by a few sug-
gestions for the directions of future research.
7.1 Summary of Contributions
The specific contributions in the three main chapters of this thesis are described as follow-
ing.
• In Chapter 3 and 4, a novel physiological biomarker extraction technique for a skin
lesion is proposed. Given that melanoma is the results of uncontrollable production
of melanin, utilizing melanin concentrations as well as hemoglobin may provide addi-
tional insights on melanoma diagnosis. Under the current diagnosis of melanoma, skin
lesions are typically acquired by standard camera, and the physiological biomarker
information are not directly available from these images. Moreover, most state-
of-the-art techniques for physiological biomarker extraction simplifies the light-skin
interaction, that only accounts for absorption only. The proposed method is de-
signed to extract the concentrations of eumelanin, pheomelanin, and hemoglobin as
an inverse function of the complex light-skin interaction model, which accounts for
reflection, scattering and absorption between various interface of skin layers.
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• In Chapter 5, the dermal radiomics sequence is constructed. While most computer-
aided melanoma screening system employs features based on ABCD-rule, the pro-
posed radiomics sequence includes not only feature sets, which are based on ABCD-
rule, but also utilizes the physiological biomarker information, which was obtained in
Chapter 3. A complete dermal radiomics sequence consists of four feature sets. First
two feature sets are low level feature, and high level intuitive feature, which quantify
ABCD criteria of the skin lesion. The last two feature sets are based on the concen-
trations of eumelanin, pheomelanin, and hemoglobin. These sets measures spatial
heterogeneity of physiological biomarkers and the texture information of lesion using
six different colour spaces. Ultimately, dermal radiomics sequence generated a total
of 395 features to thoroughly characterize each skin lesion.
• In Chapter 6, feature analysis for the proposed dermal radiomics framework is con-
ducted. First, classification analysis is performed to find an appropriate classifica-
tion algorithm for dermal radiomics. Three classification algorithms (random forest,
support vector machine, naive Bayes classification), which are widely employed for
melanoma classification, are compared. From the validation study, the random forest
classification showed the superior performance on diagnosing melanoma over other
two methods. Second, feature selection analysis is conducted to optimize the use of
dermal radiomics sequence. Different feature selection algorithms are explored and
ReliefF is chosen for the dermal radiomics as it yields the best sensitivity, specificity
and accuracy. From the feature analysis, the most effective feature selection and
classification algorithm for the dermal radiomics are chosen.
7.2 Future Research
The work motivates future research in the following directions.
• We extracted the concentrations of eumelanin, pheomelanin, and hemoglobin by using
the physiological biomarker extraction in Chapter 3. While we used this technique
for skin cancer research, this can be further extended into skin colour reproduction
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technique. In skin colour reproduction technique, melanin and hemoglobin plays
important roles for reproducing facial skin colour. It is reported that the melanin
texture of a 50 year-old woman is different than the texture of a 20 year-old woman.
Moreover, the level of hemoglobin changes due to alcohol consumption or tanning.
By measuring concentrations of melanin and hemoglobin accurately, more realistic
skin colour can be reproduced.
• The proposed melanoma screening system diagnoses either benign or malignant
melanoma, which is binary classification. As mentioned in Chapter 2, there are
four subtypes of melanoma, and treatment option could be different based on which
type of melanoma the patient has. Therefore, our system can be further investigated
to include multi-class classification. The only limitation on our study is that we did
not have sufficient image data to fully characterize each subtype of melanoma. It
would be a good direction to take if we can further analyze dermal radiomics se-
quence so that the random forest classification can diagnose subtypes of melanoma.
Moreover, not only the subtype of melanoma, but also other types of skin cancer
can be classified using the proposed screening system. While non-melanoma skin
cancer is not dangerous compared to melanoma, Merkel cell carcinoma requires more
attention because this type of cancer is not easily diagnosed in the early stage of
cancer.
• For the more accurate measurement of physiological biomarker concentrations, multi-
spectral imaging could be employed. This could be especially beneficial if oxygenated
hemoglobin and deoxygenated hemoglobin needs to be separated. Moreover, eume-
lanin and pheomelanin exhibits different spectral responses in near infra-red fre-
quency domain, thus, the multi-spectral imaging can provide an improved measure-
ment on physiological biomarkers.
• Another area of future research would be to wrap this entire melanoma screening
system into mobile application. This can help potentially those who live in remote
area, and the access to clinicians or dermatologists is limited. Moreover, this will
promote self-examination of melanoma and can lead to early detection of this type
of skin cancer. As mentioned in Chapter 2, even though melanoma has high incident
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rate, the mortality rate is relatively low because of early detection. Mobile application
of melanoma screening system can further reduce the mortality rate.
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Appendix A
Colour Space Conversion
For completeness, we summarize the colour space conversion from XYZ space to RGB,
L*a*b*, L*u*v*, xyz, and rgb.
A.1 XYZ to RGB Conversion
Conversion from CIE XYZ to RGB colour space is defined as follows:
R′ = 3.2410X − 1.5374Y − 0.4986Z, (A.1)
G′ = −0.9692X + 1.8760Y + 0.0416, (A.2)
B′ = 0.0556X − 0.2040Y + 1.0570Z, (A.3)
RGB′ represents standard RGB colour space and to obtain the RGB colours in the
correct range, an additional non-linear transform is performed. If any values of R′, G′, B′
are less than 0.0031308,
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RGB = 12.92RGB′ (A.4)
otherwise,
RGB = 1.055RGB′(1/2.4) − 0.055 (A.5)
The obtained RGB are normalized, and the correct 8-bit values are restored by multi-
plying RGB by 255.
A.2 XYZ to L*a*b* Conversion
Conversion from CIE XYZ to CIE 1976 L*,a*,b* space is defined as follows:
L∗ = 116f(Y/Yn)− 16
a∗ = 500[f(X/Xn)− f(Y/Yn)]
b∗ = 200[f(Y/Yn)− f(Z/Zn)]
(A.6)
where f(t) =
{
t1/3 if t > ( 6
29
)3
1
3
(29
6
)2t+ 4
29
otherwise
A.3 XYZ to L*u*v*
Conversion from XYZ to CIE 1976 L*, u*, v* space is defined as follows:
L∗ =
{
29
3
3
Y/Yn, Y/Yn ≤ ( 629)3
116(Y/Yn)
1/3 − 16, Y/Yn > ( 629)3
(A.7)
u∗ = 13L∗ · (u′ − u′n) (A.8)
v∗ = 13L∗ · (v′ − v′n) (A.9)
where u′ = 4X
X+15Y+3Z
, and v′ = 9Y
X+15Y+3Z
.
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A.4 XYZ to xyz
Given X,Y, and Z be the tristimulus values of a given colour, x,y,z are its chromaticity
coordinates, and are defined as:
x =
X
X + Y + Z
(A.10)
y =
Y
X + Y + Z
(A.11)
z =
Z
X + Y + Z
(A.12)
A.5 RGB to rgb
Given R, G, and B be the tristimulus values of a given colour, r,g,b are its chromaticity
coordinates, and are defined as:
r =
R
R +G+B
(A.13)
g =
G
R +G+B
(A.14)
b =
B
R +G+B
(A.15)
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